1. Camfield CS, Striano P, Camfield PR. Epidemiology of juvenile myoclonic epilepsy. Epilepsy Behav. 2013; 28 Suppl 1: S15–7. DOI: 10.1016/j.yebeh.2012.06.024

2. Hirsch E, French J, Scheffer IE, et al. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022; 63 (6): 1475–1499. DOI: 10.1111/epi.17236

3. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989; 30 (4): 389–99. DOI: 10.1111/j.1528– 1157.1989.tb05316.x

4. Schneider–von Podewils F, Gasse C, Geithner J, et al. Clinical predictors of the long–term social outcome and quality of life in juvenile myoclonic epilepsy: 20–65 years of follow–up. Epilepsia. 2014; 55 (2): 322–30. DOI: 10.1111/ epi.12491

5. Stevelink R, Koeleman BPC, Sander JW, et al. Refractory juvenile myoclonic epilepsy: a meta–analysis of prevalence and risk factors. Eur J Neurol. 2019; 26 (6): 856–864. DOI: 10.1111/ene.13811

6. Gamirova R, Shaimardanova R, Ziganshina L. Pharmacoepidemiology of antiepileptic drugs in children: comparative analysis of efficacy and safety. International Journal of Risk and Safety in Medicine. 2012; 24 (3): 179–185. DOI: 10.3233/JRS–2012–0565

7. Martínez–Juárez IE, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long–term follow–up. Brain. 2006; 129 (Pt 5): 1269–80. DOI: 10.1093/brain/awl048

8. Gesche J, Khanevski M, Solberg C, et al. Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies. Epilepsia. 2017; 58 (4): e64–e69. DOI: 10.1111/epi.13702

9. Asadi–Pooya AA, Hashemzehi Z, Emami M. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME). Seizure. 2014; 23 (10): 889–91. DOI: 10.1016/j. seizure.2014.08.004

10. Silvennoinen K, de Lange N, Zagaglia S, et al. Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy. Epilepsia Open. 2019; 4 (3): 420–430. DOI: 10.1002/epi4.12349

11. Shakeshaft A, Panjwani N, McDowall R, et al. Trait impulsivity in juvenile myoclonic epilepsy. Ann Clin Transl Neurol. 2021; 8(1): 138–152. DOI: 10.1002/acn3.51255

12. Rubboli G, Beier CP, Selmer KK, et al. Variation in prognosis and treatment outcome in juvenile myoclonic epilepsy: a Biology of Juvenile Myoclonic Epilepsy Consortium proposal for a practical definition and stratified medicine classifications. Brain Commun. 2023; 5 (3): fcad182. DOI: 10.1093/braincomms/fcad182

13. Delgado–Escueta AV, Enrile–Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology. 1984; 34 (3): 285–94. DOI: 10.1212/wnl.34.3.285

14. Leu C, Stevelink R, Smith AW, et al. Polygenic burden in focal and generalized epilepsies. Brain. 2019 Nov 1; 142 (11):3473–3481. DOI: 10.1093/brain/awz292

15. Gilsoul M, Grisar T, Delgado–Escueta AV, et al. Subtle Brain Developmental Abnormalities in the Pathogenesis of Juvenile Myoclonic Epilepsy. Front Cell Neurosci. 2019; 13: 433. DOI: 10.3389/fncel.2019.00433

16. Гамирова Р.Г., Гамирова Р.Р., Есин Р.Г. Генетика эпилепсии: успехи, проблемы и перспективы развития // Журнал неврологии и психиатрии им. С.С. Корсакова. – 2020. – Т. 120, вып. 9. – С.144–150. [Gamirova RG, Gamirova RR, Esin RG. Genetics of epilepsy: successes, problems and prospects of development [Genetics of epilepsy: successes, problems and prospects of development]. Zhurnal nevrologii I psikhiatrii imeni SS Korsakova [SS Korsakov Journal of Neurology and Psychiatry]. 2020; 120 (9): 144–150. (In Russ.)]. DOI: 10.17116/jnevro2020120091144

17. Cerulli Irelli E, Cocchi E, Ramantani G, et al. The spectrum of epilepsy with eyelid myoclonia: delineation of disease subtypes from a large multicenter study. Epilepsia. 2022. DOI: 10.1111/epi.17450

18. Reichsoellner J, Larch J, Unterberger I, et al. Idiopathic generalised epilepsy of late onset: a separate nosological entity? J Neurol Neurosurg Psychiatry. 2010; 81 (11): 1218–22. DOI: 10.1136/jnnp.2009.176651

19. The International League Against Epilepsy Consortium on Complex Epilepsies. Genome–wide mega–analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun. 2018; 9 (1): 5269. DOI: 10.1038/s41467–018–07524–z

20. Miró J, Aiguabella M, Veciana M, Juvany R, et al. Low– dose sodium valproate in the treatment of idiopathic generalized epilepsies. Acta Neurol Scand. 2014; 129 (5): e20–3

21. Hosny H, Elfayoumy N, Adly M, et al. Genetic generalized epilepsy: factors associated with drug resistance polytherapy. Egypt J Neurol Psychiatry Neurosur. 2023; 59 (4): 1–9. DOI: 10.1186/s41983–022–00604–4

22. Karakis I, Pathmanathan JS, Chang R, et al. Prognostic value of EEG asymmetries for development of drug– resistance in drug–naïve patients with genetic generalized epilepsies. Clin Neurophysiol. 2014; 125 (2): 263–9. DOI: 10.1016/j.clinph.2013.07.028

23. Kamitaki BK, Janmohamed M, Kandula P, et al. Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy. Epilepsia. 2022; 63 (1): 150–161. DOI: 10.1111/epi.17104

24. Ashmawi A, Hosny H, Gadallah M, et al. Sleep convulsive seizures predict lack of remission in genetic generalized epilepsies: a retrospective study from a single epilepsy center in Egypt. Acta Neurol Scand. 2017; 136 (5): 528–535. DOI: 10.1111/ane.12769

25. Pietrafusa N, La Neve A, de Palma L, et al. Juvenile myoclonic epilepsy: Long–term prognosis and risk factors. Brain Dev. 2021; 43 (6): 688–697. DOI: 10.1016/j. braindev.2021.02.005

26. Гамирова Р.Г., Шаймарданова Р.М. Болезнь Лафоры – трудный пациент в работе невролога // Российский вестник перинатологии и педиатрии. – 2018. – Т. 63, вып. 5. – С. 177–183. [Gamirova RG, Shaymardanova RM. Bolezn’ Lafory – trudnyj pacient v rabote nevrologa [Laforadisease – A Difficult Patient in the Neurologist’s Practice]. Rossijskij vestnik perinatologii i pediatrii [Russian Bulletin of perinatology and pediatrics]. 2018; 63 (5): 177–183. (In Russ)]. DOI: 10.21508/1027–4065–2018–63–5–177–183

27. Gomez–Ibañez A, McLachlan RS, Mirsattari SM, et al. Prognostic factors in patients with refractory idiopathic generalized epilepsy. Epilepsy Res. 2017; 130: 69–73. DOI: 10.1016/j.eplepsyres.2017.01.011

28. Ratcliffe C, Wandschneider B, Baxendale S, et al. Cognitive function in genetic generalized epilepsies: Insights from neuropsychology and neuroimaging. Front Neurol. 2020; 11: 144. DOI: 10.3389/fneur.2020.00144

29. Callenbach PM, Bouma PA, Geerts AT, et al. Long–term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood. Epilepsy Res. 2009; 83 (2–3): 249–56. DOI: 10.1016/j.eplepsyres.2008.11.011

30. Yıldırım M, Bektaş Ö, Kartal AT, et al. Risk of seizure relapse and long–term outcomes after discontinuation of antiseizure medication in children with epilepsy. Epilepsy Behav. 2022; 134: 108779. DOI: 10.1016/j.
yebeh.2022.108779

31. Liang X, Yu N, Zhang YF, Gu L, Di Q. Prognostic implications of persistent interictal epileptiform discharges on antiseizure medication withdrawal in patients with epilepsy in five–year remission. Seizure. 2022; 94: 100–106. DOI: 10.1016/j.seizure.2021.11.009

1. Блинов Д.С., Грачева Т.С., Исламова М.Н., Чугунова Л.А. Проблемы репродуктивного здоровья женщин и способы повышения репродуктивного потенциала // Огарёв–Online. – 2016. – No 15 (80). – С.10. [Blinov DS, Gracheva TS, Islamova MN, Chugunova LA. Problemy` reproduktivnogo zdorov`ya zhenshhin i sposoby` povy`sheniya reproduktivnogo potenciala [Problems of women’s reproductive health and ways to increase reproductive potential]. Ogaryov–Online [Ogarev–Online]. 2016; 15 (80): 10 p. (In Russ.)].

2. Землянова Е.В. Потери потенциальных рождений в России из–за проблем, связанных со здоровьем // Социальные аспекты здоровья населения. – 2016. – Т. 48, No 2. – С.1–15. [Zemlyanova EV. Poteri potencial`ny`x rozhdenij v Rossii iz–za problem, svyazanny`x so zdorov`em [Loss of potential births in Russia due to health–related problems]. Social`ny`e aspekty` zdorov`ya naseleniya. [Social aspects of population health]. 2016; 48 (2): 1–15 p. (In Russ.)]. DOI: 10.21045/2071–5021–2016–48–2–4

3. Гатина Г.А. Медицинские аспекты оптимизации репродуктивного здоровья женщин Дагестана. – Махачкала: Общество с ограниченной ответственностью “Издательство АЛЕФ”, 2022. – 204 с. [Gatina GA. Medicinskie aspekty` optimizacii reproduktivnogo zdorov`ya zhenshhin Dagestana [Medical aspects of optimizing the reproductive health of women in Dagestan]. Maxachkala: Obshhestvo s ogranichennoj otvetstvennost`yu “Izdatel`stvo ALEF” [Makhachkala: Limited Liability Company “ALEFPublishing House”]. 2022; 204 p. (In Russ.)]. DOI: 10.33580/9785002121229

4. Салий М.Г., Ткаченко Л.В., Селина Е.Г., [и др.]. Репродуктивный потенциал современных молодых женщин // Астраханский медицинский журнал. – 2022. – Т. 17, No 3. – С. 66–71. [Salij MG, Tkachenko LV, Selina EG, et al. Reproduktivny`j potencial sovremenny`x molody`x zhenshhin [Reproductive potential of modern young women]. Astraxanskij medicinskij zhurnal [Astrakhan Medical Journal]. 2022; 17 (3): 66–71 p. (In Russ.)]. DOI: 10.48612/ agmu/2022.17.3.66.71

5. Гладкая В.С., Грицинская В.Л., Медведева Н.Н. Современные тенденции репродуктивного здоровья и репродуктивного поведения женского населения в России // Материнство и детство. – 2017. – No1 (68). – С.10–14. [Gladkaya VS, Gricinskaya VL, Medvedeva NN. Sovremenny`e tendencii reproduktivnogo zdorov`ya i reproduktivnogo povedeniya zhenskogo naseleniya v Rossii [Modern trends in reproductive health and reproductive behavior of the female population in Russia]. Materinstvo i detstvo [Motherhood and Childhood]. 2017; 1 (68): 10–14 p. (In Russ.)].

6. Архангельский В.Н., Богдан И.В., Калачикова О.Н., Чистякова Д.П. Особенности репродуктивного поведения жительниц Москвы // Экономические и социальные перемены: факты, тенденции, прогноз. – 2023. – Т. 16, No 3. –С. 231–246. [Arxangel`skij VN, Bogdan IV, Kalachikova ON, Chistyakova DP. Osobennosti reproduktivnogo povedeniya zhitel`nicz Moskvy` [Features of reproductive behavior of Moscow residents]. E`konomicheskie i social`ny`e peremeny`: fakty`, tendencii, prognoz [Economic and social changes: facts, trends, forecast]. 2023; 16 (3): 231–246 p. (In Russ.)]. DOI: 10.15838/esc.2023.3.87.12

7. Белкин С.К. Факторы, влияющие на репродуктивное здоровье женщин // Молодежь XXI века: образование, наука, инновации: Материалы XI Всероссийской студенческой научно–практической конференции с международным участием / Под редакцией А.С. Хомченко. Часть 2. – Новосибирск: Новосибирский государственный педагогический университет, 2023. – С.81–83. [Belkin SK. Faktory`, vliyayushhie na reproduktivnoe zdorov`e zhenshhin [Factors influencing women’s reproductive health]. Molodezh` XXI veka: obrazovanie, nauka, innovacii: Materialy` XI Vserossijskoj studencheskoj nauchno–prakticheskoj konferencii s mezhdunarodny`m uchastiem; pod redakciej AS Xomchenko, Chast` 2 [Youth of the XXI century: education, science, innovation: Materials of the XI All–Russian student scientific and practical conference with international participation; Edited
   by AS Khomchenko, Part 2]. Novosibirsk: Novosibirskij gosudarstvenny`j pedagogicheskij universitet [Novosibirsk: Novosibirsk State Pedagogical University]. 2023; 81–83. (In Russ.)].

8. Ogundele OJ, Pavlova M, Groot W. Inequalities in reproductive health care use in five West–African countries: A decomposition analysis of the wealth–based gaps. Int J Equity Health. 2020; 19 (1): 44 p. DOI: 10.1186 / s12939–020–01167–7

9. Quenby S, Gallos ID, Dhillon–Smith RK, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021; 397 (10285): 1658–1667. DOI: 10.1016/S0140– 6736(21)00682–6

10. Калачикова О.Н., Шабунова А.А. Репродуктивное поведение как фактор воспроизводства населения: тенденции и перспективы: монография. – Вологда: ИСЭРТ РАН, 2015. – 172 с. [Kalachikova ON, Shabunova AA. Reproduktivnoe povedenie kak faktor vosproizvodstva naseleniya: tendencii i perspektivy`: monografiya [Reproductive behavior as a factor in population reproduction: trends and prospects: monograph.]. Vologda: ISERT RAN [Vologda: ISEDT RAS]. 2015; 172 p. (In Russ.)].

11. Артюхина В.А., Нагайцев В.В., Шрайбер А.Н. Социологическая оценка основных факторов репродуктивного поведения современных российских женщин // Вестник НГУЭУ. – 2020. – No 3. – С.251–259. [Artyuxina VA, Nagajcev VV, Shrajber AN. Sociologicheskaya ocenka osnovny`x faktorov reproduktivnogo povedeniya sovremenny`x rossijskix zhenshhin [Sociological assessment of the main factors of reproductive behavior of modern Russian women]. Vestnik NGUE`U [Bulletin of NSUEU]. 2020; 3: 251–259. (In Russ.)]. DOI: 10.34020/2073–6495–2020–3–251–259

12. Гатина Г.А. Характер реализации репродуктивной функции женщин села и города Республики Дагестан // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и технические науки. – 2022. – No 10. – С. 183–188. [Gatina GA. Kharakter realizacii reproduktivnoj funkcii zhenshhin sela i goroda Respubliki Dagestan [The nature of the implementation of the reproductive function of women in rural and urban areas of the Republic of Dagestan]. Sovremennaya nauka: aktual`ny`e problemy` teorii i praktiki; Seriya: Estestvenny`e i texnicheskie nauki [Modern science: current problems of theory and practice; Series: Natural and technical sciences]. 2022; 10: 183–188 p. (In Russ.)]. DOI: 10.37882/2223–2966.2022.10.07

1. Akhtar S, Al-Hashel JY, Alroughani R. Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasiexperimental study. BMC Neurol. 2023; 23 (1): 259. DOI: 10.1186/s12883-023-03295-3

2. Walton C, King R, Rechtman L, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020; 26 (14): 1816–1821. DOI: 10.1177/1352458520970841

3. Kingwell E, Marriott JJ, Jetté N, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013; 13: 128. DOI: 10.1186/1471-2377-13-128

4. Branco M, Alves I, Martins da Silva A, et al. The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study. BMC Neurol. 2020; 20:195. DOI: 10.1186/s12883-020-01755-8

5. GBD 2016 Multiple Sclerosis Collaborators. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18 (3): 269–285. DOI: 10.1016/S1474-4422(18)30443-5

6. Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology. 2008; 71 (2): 129–135. DOI: 10.1212/01.wnl.0000316802.35974.34

7. Poser CM, Brinar VV. The accuracy of prevalence rates of multiple sclerosis: A critical review. Neuroepidemiology. 2007;29(3-4):150-155. DOI: 10.1159/000111576

8. President of the Republic of Azerbaijan Ilham Aliyev. On the approval of the ‘State Program on the treatment, prevention and measures to combat multiple sclerosis’. No2542 13 November 2012 [Internet]. sehiyye.gov.az. Ministry of Health Republic of Azerbaijan; 2012 [cited 2024 Feb 25]. Available from: https://sehiyye.gov.az/en/ huquqi-senedler/ferman-ve-serencamlar/

9. Guliyeva A. Age and gender characteristics of patients with multiple sclerosis. Az Med Jour. 2023; 3: 108-113. DOI: 10.34921/amj.2023.3.018

10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69 (2): 292-302. DOI: 10.1002/ana.22366

11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 1983; 33 (11): 1444-1452. DOI: 10.1212/ wnl.33.11.1444

12. Lövblad K-O, Anzalone N, Dörfler A, Essig M, Hurwitz B, Kappos L, Lee S-K, Filippi M. MR imaging in multiple sclerosis: review and recommendations for current practice. AJNR Am J Neuroradio. 2010; 31 (6): 983-989. DOI: 10.3174/ajnr.A1906

13. Какие методы диагностики РС самые достоверные [Internet]. Available from: https://ms-lectures.ru/ metody-diagnostiki [Kakie metody diagnostiki RS samye dostovernye [What are the most reliable methods for diagnosing MS] [Internet]. (In Russ.)] Available from: https://ms-lectures.ru/metody-diagnostiki

14. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997; 63 (5): 565-568. DOI: 10.1136/jnnp.63.5.565

15. Balbuena LD, Middleton RM, Tuite-Dalton K, et al. Sunshine, sea, and season of birth: MS incidence in Wales. PLoS One. 2016; 11 (5): e0155181. DOI: 10.1371/journal. pone.0155181

16. Медик В.А., Лисицин В.И., Токмачев М.С. Общественное здоровье и здравоохранение: руководство к практическим занятиям: учебное пособие для медицинских вузов: [по специальностям 0601201 ‘Лечебное дело’, 060103 ‘Педиатрия’, 060105 ‘Стоматология’] [Internet]. Москва: ГЭОТАР-Медиа, 2012 [cited 2024 Feb 25]. [Medik VA, Lisicin VI, Tokmachev MS. Obshhestvennoe zdorov’e i zdravoohranenie: rukovodstvo k prakticheskim zanjatijam: uchebnoe posobie dlja medicinskih vuzov : [po special’nostjam 0601201 ‘Lechebnoe delo’, 060103 ‘Pediatrija’, 060105 ‘Stomatologija’][Public health and healthcare: a guide to practical exercises: a textbook for medical universities: [for specialties 0601201 ‘General Medicine’, 060103 ‘Pediatrics’, 060105 ‘Dentistry’] [Internet]. Moskva: GEOTAR-Media [Moscow: GEOTAR-Media]. 2012 [cited 2024 Feb 25]. (In Russ.)] Available from: https://books.google.az/books?id=OG-7WzTE-6sC

17. Гусев Е.И., Завалишин И.А., Бойко А.Н. Рассеянный склероз и другие демиелинизирующие заболевания // Москва: Миклош, 2004. – 540 с. [Gusev EI, Zavalishin IA, Bojko AN Rassejannyj skleroz i drugie demielinizirujushhie zabolevanija [Multiple sclerosis and other demyelinating diseases]. Moskva: Miklosh [Moscow: Miklosh]. 2004; 540 p. (In Russ.)]

18. Türk Börü Ü, Duman A, Kulualp AŞ, et al. Multiple sclerosis prevalence study: The comparison of 3 coastal cities, located in the black sea and mediterranean regions of Turkey. Medicine Balt. 2018; 97 (42): e12856. DOI: 10.1097/MD.0000000000012856

19. Hashemilar M, Ouskui DS, Farhoudi M, et al. Multiple sclerosis in East Azerbaijan, North West Iran. Neurol Asia. 2011; 16 (2): 127-131.

20. Correa-Díaz EP, Ortiz MA. Prevalence of multiple sclerosis in Cuenca, Ecuador. Mult Scler J Exp Transl Clin. 2019; 5 (4): 2055217319884952. DOI: 10.1177/2055217319884952

21. Kotzamani D, Panou T, Mastorodemos V, et al. Rising incidence of multiple sclerosis in females associated with urbanization. Neurology. 2012; 78 (22): 1728-1735. DOI: 10.1212/WNL.0b013e31825830a9

22. Browne P, Chandraratna D, Angood C, et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014; 83 (11): 1022–1024. DOI: 10.1212/WNL.0000000000000768

23. Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States. Neurology. 2019; 92 (10): e1029–e1040. DOI: 10.1212/ WNL.0000000000007035

1. Тanase I, Paun S, Stoica B, Negoi I, et al. Epidemiology of diverticular disease – systematic review of the literature. Chirurgia (Bucur). 2015; 110 (1): 9–14.

2. Ogunbiyi OA. Diverticular disease of the colon in Ibadan, Nigeria. Afr J Med Med Sci. 1989; 18: 241–244.

3. Sugihara K, Muto T, Morioka Y et al. Diverticular disease of the colon in Japan. A review of 615 cases. Dis Colon Rectum. 1984; 27: 531–537.

4. Gordon PH. Principles and practice of surgery for the colon, rectum, and anus. By Philip H Gordon, Santhat Nivatvongs. 2007; 3rd ed: 949 p.

5. Pourfarziani V, Mousavi-Nayeeni SM, Ghaheri H et al. The outcome of diverticulosis in kidney recipients with polycystic kidney disease. Transplant Proc. 2007; 39: 1054–1056. DOI: 10.1016/j.transproceed.2007.02.007

6. Qasabian RA, Meagher AP, Lee R et al. Severe diverticulitis after heart, lung, and heart–lung transplantation. J Heart Lung Transplant. 2004; 23: 845–849. DOI: 10.1016/j. healun.2003.07.019

7. Klarenbeek BR, Samuels M, van der Wal MA et al. Indications for elective sigmoid resection in diverticular disease. Ann Surg. 2010; 251: 670–674. DOI: 10.1097/ SLA.0b013e3181d3447d

8. Biondo S, Borao JL, Kreisler E et al. Recurrence and virulence of colonic diverticulitis in immunocompromised patients. Am J Surg. 2012; 204: 172–179. DOI: 10.1016/j. amjsurg.2011.09.027

9. Feingold D, Steele S, Lee S et al. Practice parameters for the treatment of sigmoid diverticulitis. Dis Colon Rectum. 2014; 57: 284–294. DOI: 10.1097/ DCR.0000000000000075

10. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1975; 4: 53–69.

11. Bahadursingh AM, Virgo KS, Kaminski DL et al. Spectrum of disease and outcome of complicated diverticular disease. Am J Surg. 2003; 186: 696–701. DOI: 10.1016/j. amjsurg.2003.08.019

12. Тимербулатов М.В., Гайнутдинов Ф.М., Мехдиев Д.И., [и др.]. Дивертикулярная болезнь толстой кишки, осложненная свищами // Колопроктология. – 2013. – No 30 (45). – C.10–27. [Timerbulatov MV, Gajnutdinov FM, Mehdiev DI, et al. Divertikuljarnaja bolezn’ tolstoj kishki, oslozhnennaja svishhami [Diverticular disease complicated by fistulas]. Koloproktologija [Koloproktologia]. 2013; 30 (45): 10–27. (In Russ.)].

13. Шелыгин Ю.А., Ачкасов С.И., Москалев А.И., [и др.]. Толстокишечно–мочепузырные свищи как осложнение дивертикулярной болезни // Урология. – 2013. – No 1. – C.17–23. [Shelygin JuA, Achkasov SI, Moskalev AI, et al. Tolstokishechno–mochepuzyrnye svishhi kak oslozhnenie divertikuljarnoj bolezni [Colovesical fistulas as complication of diverticular disease]. Urologija [Urology]. 2013; 1: 17–23. (In Russ.)].

14. Poos RJ. Kolon diverticulitis. In: Beger HG, Kern E (Hrsg); Akutes Abdomen. New York: Thieme, Stuttgart. 1987; 3: 243–258.

15. Tursi A, Elisei W. Role of Inflammation in the Pathogenesis of Diverticular Disease. Mediators Inflamm. 2019: 8328490. DOI: 10.1155/2019/8328490

16. Falconi M, Pederzoli P. The relevance of gastrointestinal fistulae in clinical practice: a review. Gut. 2002; 49: 2–10. DOI: 10.1136/gut.49.suppl. 4.iv2

17. Ардатская М.Д., Ачкасов С.И., Веселов В.В., [и др.]. Дивертикулярная болезнь //Колопроктология. – 2021. – No 20 (3). – С.10–27. [Ardatskaja MD, Achkasov SI, Veselov VV, et al. Divertikuljarnaja bolezn’ [Diverticular disease]. Koloproktologija [Koloproktologia]. 2021; 20 (3): 10–27. (In Russ.)]. DOI: 10.33878/2073–7556–2021–20–3–10–27

18. Орлова Л.П., Ачкасов С.И., Трубачева Ю.Л., [и др.]. Ультразвуковое исследование в диагностике дивертикулярной болезни ободочной кишки и её хронических воспалительных осложнений // Колопроктология. – 2013. – No 1(43). – С.19–27. [Orlova LP, Achkasov SI, Trubacheva JuL, et al. Ul’trazvukovoe issledovanie v diagnostike divertikuljarnoj bolezni obodochnoj kishki i ejo hronicheskih vospalitel’nyh oslozhnenij [Abdominal ultrasound in diagnosticts of diverticluar disease]. Koloproktologija [Koloproktologia]. 2013; 1 (43): 19–27. (In Russ.)].

19. Hincey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg. 1978; 12: 85–109.

20. Панкратова Ю.С., Карпухин О.Ю., Зиганшин М.И. [и др.]. Толстокишечный инвагинационный анастомоз в хирургии осложненных форм дивертикулярной болезни ободочной кишки // Колопроктология. – 2021. – No 20 (4). – С.42–48. [Pankratova JuS, Karpuhin OJu, Ziganshin MI, et al. Tolstokishechnyj invaginacionnyj anastomoz v hirurgii oslozhnennyh form divertikuljarnoj bolezni obodochnoj kishki [Colonic invagination anastomosis in surgery of complicated forms of diverticular disease]. Koloproktologija [Koloproktologia]. 2021; 20 (4): 42–48. (In Russ.)]. DOI: 10.33878/2073–7556–2021–20–4–42–48

1. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Клинические рекомендации // Москва, 2021. – 79 с. [Preeklampsiya; Eklampsiya; Oteki, proteinuriya i gipertenzivnye rasstrojstva vo vremya beremennosti, v rodah i poslerodovom periode: Klinicheskie rekomendacii [Preeclampsia; Eclampsia; Edema, proteinuria and hypertensive disorders during pregnancy, childbirth and the postpartum period: Clinical guidelines]. Moskva [Moscow]. 2021; 79 р. (In Russ.)]. Режим доступа (URL): https://cr.minzdrav.gov.ru/schem a/637_1?ysclid=lwqwr88c9d803445769

2. Сидорова И.С., Никитина Н.А., Агеев М.Б., [и др.]. Современные возможности транскриптомики в изучении преэклампсии // Акушерство и гинекология. – 2022. – No7. – С.5–12. [Sidorova IS, Nikitina NA, Ageev MB, et al. Sovremennye vozmozhnosti transkriptomiki v izuchenii preeklampsii [Modern possibilities of transcriptomics in the study of preeclampsia]. Akusherstvo i ginekologiya [Obstetrics and gynecology]. 2022; 7: 5–12. (In Russ.)]. DOI: 10.18565/aig.2022.7.5–12

3. Ren Z, Gao Y, Gao Y, et al. Distinct placental molecular processes associated with early–onset and late–onset preeclampsia. Theranostics. 2021; 11 (10): 5028–44. DOI: 10.7150/thno.56141

4. Сидорова И.С., Никитина Н.А. Критические формы преэклампсии // Российский вестник акушера–гинеколога. – 2017. – Т.17, No6. – С.4–8. [Sidorova IS, Nikitina NA. Kriticheskie formy preeklampsii[Critical forms of preeclampsia]. Rossijskij vestnik akushera–ginekologa [Russian Bulletin of Obstetrician–Gynecologist]. 2017; 17 (6): 4–8.(In Russ.)]. DOI: 10.17116/rosakush20171764–8

5. Макацария А.Д., Акиншина С. В., Бицадзе В. О., [и др.]. Тяжелые акушерские осложнения как проявление тромботической микроангиопатии // Журнал акушерства и женских болезней. – 2015. – Т. 64, No5. – С.6–15. [Makacariya AD, Akinshina SV, Bicadze VO, et al. Tyazhelye akusherskie oslozhneniya kak proyavlenie tromboticheskoj mikroangiopatii [Severe obstetric complications as a manifestation of thrombotic microangiopathy]. Zhurnal akusherstva i zhenskih boleznej [Journal of Obstetrics and Women’s Diseases]. 2015; 64 (5): 6–15. (In Russ.)].

6. Маркова К.Л., Коган И.Ю., Шевелева А.Р., [и др.]. Микровезикулы лейкоцитарного происхождения // Вестник Российской академии медицинских наук. – 2018. – Т.73, No 6. – С. 378–387. [Markova KL, Kogan IYu, Sheveleva AR, et al. Mikrovezikuly lejkocitarnogo proiskhozhdeniya[Microvesicles of leukocyte origin]. Vestnik Rossijskoj akademii medicinskix nauk [Bulletin of the Russian Academy of Medical Sciences]. 2018; 73 (6): 378–387. (In Russ.)]. DOI: 10.15690/vramn1031

7. Гомзикова М.О., Гайфуллина Р.Ф., Мустафин И.Г., [и др.]. Мембранные микровезикулы: биологические свойства и участие в патогенезе заболеваний // Гены и клетки. – 2013.– Т.8, No 1. – С.6–11. [Gomzikova MO, Gajfullina RF, Mustafin IG, et al. Membrannye mikrovezikuly: biologicheskie svojstva i uchastie v patogeneze zabolevanij [Membrane microvesicles: biological properties and participation in the pathogenesis of diseases]. Geny i kletki [Genes and cells]. 2013; 8 (1): 6–11. (In Russ.)].

8. Момот А.П., Царигородцева Н.О., Фёдоров Д.В., и др. Тромбоцитарные микровезикулы и их роль в обеспечении гемостатического потенциала (обзор литературы) // Сибирский научный медицинский журнал. – 2020. – Т. 40, No 2. – С.1–14. [Momot AP, Carigorodceva NO, Fyodorov DV, et al. Trombocitarnye mikrovezikuly i ih rol’ v obespechenii gemostaticheskogo potenciala (obzor literatury) [Platelet microvesicles and their role in providing hemostatic potential (literature review)]. Sibirskij nauchnyj medicinskij zhurnal [Siberian Scientific Medical Journal]. 2020; 40 (2): 1–14. (In Russ.)]. DOI: 10.15372/ SSMJ20200201

9. Мустафин И.Г. Д.М. Зубаиров и его научная школа // Казанский медицинский журнал. – 2011. – Т. 92, No 5. – С.670–671. [Mustafin IG. DM Zubairov i ego nauchnaya shkola [DM Zubairov and his scientific school]. Kazanskij medicinskij zhurnal [Kazan Medical Journal]. 2011; 92 (5): 670–671.(In Russ.)].

10. Галеева С.А., Таджибоева Н.А. Роль микровезикул тромбоцитов в патогенезе преэклампсии // Казанский медицинский журнал. – 2022. – Т.103, No 4. – С. 641–649. [Galeeva SA, Tadzhiboeva NA. Rol’ mikrovezikul trombocitov v patogeneze preeklampsii [The role of platelet microvesicles in the pathogenesis of preeclampsia]. Kazanskij medicinskij zhurnal [Kazan Medical Journal]. 2022; 103 (4): 641–649. (In Russ.)]. DOI: 10.17816/ KMJ2022–641

11. Николаева М.Г., Терехина В. Ю., Кудинов А. В., [и др.]. Роль экстраклеточных везикул различного происхождения в развитии преэклампсии // Вестник Российской академии медицинских наук. – 2021.– Т.76, No3. – С.237– 243. [Nikolaeva MG, Terekhina VYu, Kudinov AV, et al. Rol’ ekstrakletochnyh vezikul razlichnogo proiskhozhdeniya v razvitii preeklampsii [The role of extracellular vesicles of various origins in the development of preeclampsia]. Vestnik Rossijskoj akademii medicinskix nauk [Bulletin of the Russian Academy of Medical Sciences]. 2021; 76 (3): 237–243.(In Russ.)]. DOI: 10.15690/vramn1369

12. Levine L, Habertheuer A, Ram C, et al. Syncytiotrophoblast extracellular microvesicle profiles in maternal circulation for noninvasive diagnosis of preeclampsia. Sci Rep. 2020 Apr 14; 10 (1): 6398. DOI: 10.1038/s41598–020–62193–7

13. Brown GC. The endotoxin hypothesis of neurodegeneration. Journal of neuroinflammation. 2019; 16 (1): 180. DOI:10.1186/s12974–019–1564–7

14. Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet– dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 2011; 118 (7): 1952–1961. DOI:10.1182/ blood–2011–03–343061

15. Nightingale T, Cutler D. The secretion of von Willebrand factor from endothelial cells;an increasingly complicated story. J Thromb Haemost. 2013; 11 (suppl 1): 192–201. DOI:10.1111/jth.12225

16. Pawlinski R, Mackman N. Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res. 2010; 125: S70e3. DOI:10.1016/j.thromres.2010.01.042

17. Thiemermann C, Ruetten H, Wu CC, et al. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol. 1995; 116: 2845–2851. DOI:10.1111/j.1476–5381.1995.tb15935.x

18. Бондаренко К.Р., Мавзютов А.Р., Озолиня Л.А. Роль системной эндотоксинемии в патогенезе гестоза // Вестник Российского государственного медицинского университета. – 2013. – No3. – С.40–43. [Bondarenko KR, Mavzyutov AR, Ozolinya LA. Rol’ sistemnoj endotoksinemii v patogeneze gestoza [The role of systemic endotoxemia in the pathogenesis of gestosis]. Vestnik Rossijskogo gosudarstvennogo medicinskogo universiteta [Bulletin of the Russian State Medical University]. 2013; 3: 40–43. (In Russ.)].

19. Contreras A, Herrera JA, Soto JE, et al. Periodontitis is associated with preeclampsia in pregnant women. Journal of periodontology. 2006; 77 (2): 182–188. DOI:10.1902/ jop.2006.050020

20. Huang X, Wang J, Liu J, et al. Maternal periodontal disease and risk of preeclampsia: a meta–analysis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 2014; 34: 729–735. DOI:10.1007/ s11596–014–1343–8

1. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008; 31 (1): 143-178. DOI: 10.1183/09031936.00138707

2. Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr. 2019; 7: 246. DOI: 10.3389/fped.2019.00246

3. Schiffers C, Wouters EF, Breyer-Kohansal R, et al. Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study. J Asthma Allergy. 2023; 16: 367-382. DOI: 10.2147/JAA.S402326

4. He X, Cheng G, He L, et al. Adults with current asthma but not former asthma have higher all-cause and cardiovascular mortality: a population-based prospective cohort study. Sci Rep. 2021; 11: 1329. DOI: 10.1038/ s41598-020-79264-4

5. Chuchalin AG, Khaltaev N, Antonov NS, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014; 9: 963–974. DOI: 10.2147/COPD.S67283

6. Быстрицкая Е.В., Биличенко Т.Н. Обзор общей заболеваемости населения Российской Федерации бронхиальной астмой // Пульмонология. – 2022. – Т.32, No5 – С. 651–660. [Bystritskaya EV, Bilichenko TN. Obzor obshchej zabolevaemosti naseleniya Rossijskoj Federacii bronhial’noj astmoj [Review of the overall incidence of bronchial asthma in the Russian Federation]. Pul’monologiya [Pulmonology]. 2022; 32 (5): 651-660. (In Russ.)]. DOI: 10.18093/0869-0189-2022-32-5-651-660

7. Li J, Ye L, She J, Song Y. Clinical Differences between Early - and Late-Onset Asthma: A Population-Based Cross- Sectional Study. Can Respir J. 2021; 2021:8886520. DOI: 10.1155/2021/8886520

8. Agache I, Eguiluz-Gracia I, Cojanu C, et al. Advances And Highlights In Asthma In 2021. Allergy. 2021; 76: 3390–3407. DOI: 10.1111/all.15054

9. Kavanagh J, Jackson DJ, Kent BK. A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma. Breathe. 2019; 15: 20–27. DOI: 10.1183/ 20734735.0362-2018

10. Toppila-Salmi S, Lemmetyinen R, Chanoine S, et al. Risk Factors For Severe Adult-Onset Asthma: A Multi-Factor Approach. BMC Pulmonary Medicine. 2021; 21: 214 DOI: 10.1186/s12890-021-01578-4

11. Ilmarinen P, Pardo A, Tuomisto LE, et al. Long-Term Prognosis Of New Adult-Onset Asthma In Obese Patients. Eur Respir J. 2021; 57: 2001209. DOI: 10.1183/13993003.01209-2020

12. Baek EJ, Jung HU, Ha TW, et al. Genome-Wide Interaction Study Of Late-Onset Asthma With Seven Environmental Factors Using A Structured Linear Mixed Model In Europeans. Front Genet. 2022; 13: 765502. DOI: 10.3389/ fgene.2022.765502

13. Thomson NC, Polosa R., Sin GG. Cigarette Smoking and Asthma. J Allergy Clin Immunol Pract. 2022; 10 (11): 2783-2797. DOI: 10.1016/j.jaip.2022.04.034

14. Sharma S, Tasnim N, Agadi K, et al. Vulnerability For Respiratory Infections In Asthma Patients: A Systematic Review. Cureus. 2022; 14 (9): e28839. DOI: 10.7759/ cureus.28839

15. Quirce S, Heffler E, Nenasheva N, et al. Revisiting Late-Onset Asthma: Clinical Characteristics and Association with Allergy. J Asthma Allergy. 2020; 13: 743-752. DOI: 10.2147/JAA.S282205

16. Ilmarinen P, Tuomisto LE, Kankaanranta H. Phenotypes, risk factors, and mechanisms of adult-onset asthma. Mediators. Inflamm. 2015; 2015: 514868. DOI: 10.1155/2015/514868

17. Sá-Sousa A, Pereira AM, Almeida R, et al. Adult Asthma Scores-Development And Validation Of Multivariable Scores To Identify Asthma In Surveys. Allergy Clin Immunol Pract. 2019; 7 (1): 183-190. DOI: 10.1016/j.jaip.2018.06.0

18. Smit HA, Pinart M, Antó JM, et al. Childhood asthma prediction models: a systematic review. Lancet Respir Med. 2015; 3: 973-984. DOI: 10.1016/S2213-2600(15)00428-2

19. Sá-Sousa A, Jacinto T, Azevedo LF, et al. Operational definitions of asthma in recent epidemiological studies are inconsistent. Clin Transl Allergy. 2014; 4: 24; DOI: 10.1186/2045-7022-4-24

20. Pekkanen J, Sunyer J, Anto JM, Burney P on behalf of the European Community Respiratory Health Study (ECRHS). Eur Respir J. 2005; 26: 28-35. DOI: 10.1183/09031936. 05.00120104

21. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., [и др.]. Бронхиальная астма: федеральные клинические рекомендации по диагностике и лечению; Межрегиональная общественная организация «Российское респираторное общество», Российская ассоциация аллергологов и клинических иммунологов, Союз педиатров России // Пульмонология. – 2022. – Т. 32, No 3. – С.393-447. [Chuchalin AG, Avdeev SN, Ajsanov ZR et al. Bronxial`naya astma: federal`ny`e klinicheskie rekomendacii po diagnostike i lecheniyu; Mezhregional’naya obshchestvennaya organizaciya «Rossijskoe respiratornoe obshchestvo», Rossijskaya associaciya allergologov i klinicheskih immunologov, Soyuz pediatrov Rossii. [Federal guidelines on diagnosis and treatment of bronchial asthma; Interregional Public Organization “Russian Respiratory Society”, Russian Association of Allergology and Clinical Immunology, The Union of Pediatricians of Russia]. Pul`monologiya [Pulmonology]. 2022; 32 (3): 393-447. (In Russ.)]. DOI: 10.18093/0869-0189-2022-32-3-393-447

22. Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 14: 902–907. DOI: 10.1034/j.1399-3003.1999.14d29.x

23. Mendy A, Mersha TB. Comorbidities in childhood-onset and adult-onset asthma. Ann Allergy Asthma Immunol. 2022; 129 (3): 327-334. DOI: 10.1016/j.anai.2022.05.005. DOI: 10.1016/ j.anai.2022.05.005

24. Quirce S, Heffler E, Nenasheva N, et al. Revisiting late-onset asthma: clinical characteristics and association with allergy. J Asthma Allergy. 2020; 13: 743–752. DOI: 10.2147/JAA.S282205

1. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013; 34: 2746–2751. DOI: 10.1093/eurheartj/eht280

2. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics–2022 Update: A Report From the American Heart Association. Circulation. 2022; 145 (8): 153–639. DOI: 10.1161/CIR.0000000000001052

3. Healey JS, Oldgren J, Ezekowitz M, et al. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. Lancet. 2016; 388 (10050): 1161–1169. DOI: 10.1016/ S0140–6736(16)30968–0

4. Marijon E, Le Heuzey JY, Connolly S, et al. Causes of death and influencing factors in patients with atrial fibrillation: a competing–risk analysis from the randomized evaluation of long–term anticoagulant therapy study. Circulation. 2013; 128 (20): 2192–2201. DOI: 10.1161/CIRCULATIO-NAHA.112.000491

5. Rienstra M, Lyass A, Murabito JM, et al. Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study. Am Heart J. 2013; 166: 171–178. DOI: 10.1016/j.ahj.2013.02.025

6. Zhang L, Gallagher R, and Neubeck L. Health–related quality of life in atrial fibrillation patients over 65 years: a review. Eur J Prev Cardiol. 2015; 22: 987–1002. DOI: 10.1177/2047487314538855

7. Rienstra M, Lubitz SA, Mahida S, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012; 125 (23): 2933–2943. DOI: 10.1161/ CIRCULATIONAHA.111.069450

8. Галяутдинов Г.С., Менделевич В.Д., Жидяевский А.Г., Нестерина М. К. Психосоциальная адаптация пациентов к хроническим сердечно–сосудистым заболеваниям // Вестник современной клинической медицины. – 2023. – Т. 16, вып. 1. – С.80–88. [Galyautdinov GS, Mendelevich VD, Zhidyaevskij AG, Nesterina MK. Psihosocial’naya adaptaciya pacientov k hronicheskim serdechno–sosudistym zabolevaniyam [Psychosocial adaptation of patients with chronic cardiovascular disease]. Vestnik sovremennoj klinicheskoj mediciny [The Bulletin of Contemporary Clinical Medicine]. 2023; 16(1): 80–88. (In Russ.)]. DOI: 10.20969/VSKM.2023.16(1).80–88

9. Wyse DG. Overview of endpoints in atrial fibrillation studies. Heart Rhythm. 2004; 1 (2 Suppl): 3–7, discussion B7. DOI: 10.1016/j.hrthm.2004.03.070

10. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio–Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42 (5): 373–498. DOI: 10.1093/eurheartj/ehaa612

11. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace. 2007; 9 (11): 1006–1023. DOI: 10.1093/europace/eum191

12. Wynn GJ, Todd DM, Webber M, et al. The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification. Europace. 2014; 16 (7): 965–972. DOI: 10.1093/europace/eut395

13. Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю., [и др.]. Клинические рекомендации РКО – ВНОА – АССХ. Фибрилляция и трепетание предсердий // Российский кардиологический журнал. – 2021. – No 26 (7). – С.190–260. [RKO – VNOA – ASSH. Klinicheskie rekomendacii: Fibrillyaciya i trepetanie predserdij [Clinical guidelines for Atrial fibrillation and atrial flutter]. Rossijskij kardiologicheskij zhurnal [Russian Journal of Cardiology]. 2021; 26 (7):190–260. (In Russ.)]. DOI: 10.15829/1560– 4071–2021–4594

14. Goldman L, Hashimoto B, Cook EF, et al. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981; 64 (6): 1227–34. DOI: 10.1161/01.cir.64.6.1227

15. Brazier JE, Harper R, Jones NM, et al. Validating the SF–36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992; 305 (6846): 160–164. DOI: 10.1136/bmj.305.6846.160

16. SF–36: Анкета оценки качества жизни. [SF–36: Anketa ocenki kachestva zhizni [SF–36. Quality of Life Questionnaire. (In Russ.)]. Режим доступа [URL]: https:// therapy.irkutsk.ru/doc/sf36.pdf

17. Magnussen C, Niiranen TJ, Ojeda FM, et al. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation. 2017; 136: 1588–1597. DOI: 10.1161/ CIRCULATIONAHA.117.028981

18. Ware J Jr, Kosinski M, Keller SD. A 12–Item Short–Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34 (3): 220–233. DOI: 10.1097/00005650–199603000–00003

19. Ware JE, Kosinski M, Dewey JE, et al. How to score and interpret single–item health status measures: a manual for users of the SF–8TM Health Survey. Health Assessment Lab. 2001. URL: https://www.semanticscholar.org/paper/ How-to-score-and-interpret-single-item-health-a-for-Ware-Kosinski/58853f98cfb44636b81a36ea1585b22985ce1bd3

20. Ng DL, Malik NMBA, Chai CS, et al. Time in therapeutic range, quality of life and treatment satisfaction of patients on long–term warfarin for non–valvular atrial fibrillation: a cross–sectional study. Health Qual Life Outcomes. 2020; 18 (1): 347. DOI: 10.1186/s12955–020–01600–z

21. Yamashita, Takeshi et al. A new method for evaluating quality of life specific to patients with atrial fibrillation: Atrial fibrillation quality of life questionnaire (AFQLQ). Japanese Journal of Electrocardiology. 2003; 23: 332–343.

22. Dorian P, Cvitkovic SS, Kerr CR, et al. A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS–SAF scale. Can J Cardiol. 2006; 22 (5): 383–386. DOI: 10.1016/s0828–282x(06)70922–9

23. Härdén M, Nyström B, Kulich K, et al. Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation. Health Qual Life Outcomes. 2009; 7: 65. DOI: 10.1186/1477–7525–7–65

24. Arribas F, Ormaetxe JM, Peinado R, et al. Validation of the AF–QoL, a disease–specific quality of life questionnaire for patients with atrial fibrillation. Europace. 2010; 12(3): 364–370. DOI: 10.1093/europace/eup421

25. AF Effect on Quality – of – Life questionnaire. URL: https://www.cardiovascular.abbott/us/en/campaigns/ afeqt.html

26. Spertus J, Dorian P, Bubien R, et al. Development and validation of the Atrial Fibrillation Effect on QualiTy–of–Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2011; 4 (1): 15–25. DOI: 10.1161/CIRCEP.110.958033

27. Walfridsson U, Arestedt K, Stromberg A. Development and validation of a new Arrhythmia–Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden. Health Qual Life Outcomes. 2012; 10: 44. DOI: 10.1186/1477–7525–10–44

28. Arrhythmia Specific questionnaire in Tachycardia and Arrhythmia. URL: https://asta.walraf.se/en/start–2

29. Walfridsson U, Walfridsson H, Middeldorp ME, et al. Validation of the English version of the arrhythmia–specific questionnaire in tachycardia and arrhythmia (ASTA): a Rasch evaluation study. J Patient Rep Outcomes. 2022; 6 (1): 90. DOI: 10.1186/s41687–022–00493–4

30. Koci F, Forbes P, Mansour MC, et al. New classification scheme for atrial fibrillation symptom severity and burden. Am J Cardiol. 2014; 114 (2): 260–265. DOI: 10.1016/j. amjcard.2014.04.032

31. Medin J, Arbuckle R, Abetz L, et al. Development and validation of the AFSympTM: an atrial fibrillation–specific measure of patient–reported symptoms. Patient. 2014; 7 (3): 319–327. DOI: 10.1007/s40271–014–0058–z

32. Coyne KS, Edvardsson N, Rydén A. Development and Validation of the AFImpact: An Atrial Fibrillation–Specific Measure of Patient–Reported Health–Related Quality of Life. Value Health. 2017; 20 (10): 1355–1361. DOI: 10.1016/j.jval.2017.06.005

33. Патент No 2314016 C1 Российская Федерация, МПК A61B 5/00. Способ диагностики степени тяжести пароксизмов мерцательной аритмии у больных с сопутствующими обструктивными заболеваниями легких: No2006113100/14: заявл. 18.04.2006: опубл. 10.01.2008 / Ю.А. Зонова, О.А. Зонов; заявитель государственное образовательное учреждение высшего профессионального образования Кировская государственная медицинская академия Росздрава. – 11 с. [Zonova JA, Zonov OA. Patent No 2314016 C1 Rossiiskaya Federaciya, MPK A61B 5/00: Sposob diagnostiki stepeni tyazhesti paroksizmov mercatel’noj aritmii u bol’nyh s soputstvuyushchimi obstruktivnymi zabolevaniyami legkih: No 2006113100/14: zaiavlenie 18/04/2006: opublikovano 10/01/2008 [Patent No 2314016 C1 Russian Federation, IPC A61B 5/00: Method for predicting the degree of fibrillation arrhythmia paroxysms in patients with accompanying obstructive pulmonary diseases: No 2006113100/14: pending 18/04/2006: published 10/01/2008]. Gosudarstvennoye obrazovatel’noye uchrezhdeniye vysshego professional’nogo obrazovaniya Kirovskaya gosudarstvennaya meditsinskaya akademiya Roszdrava State [State educational institution of higher professional education Kirov State Medical Academy of Roszdrav]. 2008; 11 p. (In Russ.)].

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Canc J Clin. 2021; 71 (3): 209–249. DOI: 10.3322/caac.21660

2. Максимова П.Е., Голубинская Е.П., Сеферов Б.Д., Зяблицкая Е.Ю. Колоректальный рак: эпидемиология, канцерогенез, молекулярно-генетические и клеточные механизмы резистентности к терапии (аналитический обзор) // Колопроктология. – 2023. – No 22 (2). – С. 160–171. [Maksimova PE, Golubinskaya EP, Seferov BD, Zyablickaya EYu. Kolorektal’nyj rak: epidemiologiya, kancerogenez, molekulyarno-geneticheskie i kletochnye mekhanizmy rezistentnosti k terapii (analiticheskij obzor) [Colorectal cancer: epidemiology, carcinogenesis, molecular genetic and cellular mechanisms of resistance to therapy (analytical review)]. Koloproktologiya [Coloproctology]. 2023; 22 (2): 160–171. (in Russ.)]. DOI: 10.33878/2073-7556-2023-22-2-160-171

3. Каприн А.Д., Старинский В.В, Шахзадов А.О. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность) // М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минз-драва России. – 2022. – 252 с. [Kaprin AD, Starinskij VV, SHahzadov AO. Zlokachestvennye novoobrazovaniya v Rossii v 2021 godu (zabolevaemost’ i smertnost’) [Malignant neoplasms in Russia in 2021 (morbidity and mortality)]. Moskva: MNIOI imeni PA Gercena — filial FGBU «NMIC radiologii» Minzdrava Rossii [Moscow: MNIOI named after PA Herzen - branch of the Federal State Budgetary Institution “National Medical Research Center of Radiology” of the Ministry of Health of Russia]. 2022; 252 p. (in Russ.)].

4. Крашенков О.П., Костин А.А., Коновалов О.Е. Гендерные особенности заболеваемости колоректальным раком // Современные проблемы эпидемиологии, микробиологии и гигиены: Сборник материалов XV Всероссийской научно-практической конференции молодых ученых и специалистов Роспотребнадзора. – Нижний Новгород: Медиаль, 2023. – C.102-105. [Krashenkov OP, Kostin AA, Konovalov OE. Gendernye osobennosti zabolevaemosti kolorektal’nym rakom; Sovremennye problemy epidemiologii, mikrobiologii i gigieny: Sbornik materialov XV Vserossijskoj nauchnoprakticheskoj konferencii molodyh uchenyh i specialistov Rospotrebnadzora [Gender characteristics of colorectal cancer incidence; Modern problems of epidemiology, microbiology and hygiene: Collection of materials of the XV All-Russian Scientific and Practical Conference of Young Scientists and Specialists of Rospotrebnadzor]. Nizhnij Novgorod: Medial’ [Nizhny Novgorod: Medial]. 2023; 102-105. (in Russ.)].

5. Куловская Д.П., Шелыгин Ю.А., Фролов С.А., Ачкасов С.И. Валидация опросника по оценке степени риска обнаружения колоректального рака // Колопроктология. – 2023. – No 22 (3). – С.76–84. [Kulovskaya DP, Shelygin YuA, Frolov SA, Achkasov SI. Validaciya oprosnika po ocenke stepeni riska obnaruzheniya kolorektal’nogo raka [Validation of a questionnaire to assess the risk of detecting colorectal cancer]. Koloproktologiya [Coloproctology]. 2023; 22 (3): 76–84. (in Russ.)]. DOI: 10.33878/2073-7556-2023-22-3-76-84

6. Зитта Д.В., Субботин В.М., Бусырев Ю.Б. Использование протокола «fast track» у больных колоректальным раком старческого возраста // Колопроктология. – 2016. – No 1. – С.26-29. [Zitta DV, Subbotin VM, Busyrev YUB. Ispol’zovanie protokola «fast track» u bol’nyh kolorektal’nym rakom starcheskogo vozrasta [Using the “fast track” protocol in elderly patients with colorectal cancer]. Koloproktologiya [Coloproctology]. 2016; 1: 26-29. (in Russ.)]. DOI: 10.33878/2073-7556-2016-0-1-26-29

7. Черниченко М.А., Сидоров Д.В. Послеоперационные осложнения после комбинированного и хирургического лечения больных раком нижнеампулярного отдела прямой кишки // Актуальные вопросы фундаментальной и клинической медицины: Сборник материалов конгресса молодых ученых, Томск, 24–25 мая 2018 года / Под редакцией Е.Л. Чойнзонова. – Томск: Национальный исследовательский Томский государственный университет, 2018. – С.352-353. [Chernichenko MA, Sidorov DV. Posleoperatsionnyye oslozhneniya posle kombinirovannogo i khirurgicheskogo lecheniya bol’nykh rakom nizhneampulyarnogo otdela pryamoy kishki; Aktual’nyye voprosy fundamental’noy i klinicheskoy meditsiny : Sbornik materialov kongressa molodykh uchenykh, Tomsk, 24–25 maya 2018 goda, pod redaktsiyey YEL Choynzonova [Postoperative complications after combined and surgical treatment of patients with lower ampullary rectal cancer; Current issues in fundamental and clinical medicine: Collection of materials from the Congress of Young Scientists, Tomsk, May 24–25, 2018, edited by EL Choinzonov]. Tomsk: Natsional’nyy issledovatel’skiy Tomskiy gosudarstvennyy universitet [Tomsk: National Research Tomsk State University]. 2018; 352-353. (in Russ.)].

8. Чиссов В.И., Старинский В.В., Ковалев Б.Н. Состояние онкологической помощи населению Российской федерации // Российский онкологический журнал. – 2016. – No 1. – С. 5. [Chissov VI, Starinskij VV, Kovalev BN. Sostoyanie onkologicheskoj pomoshchi naseleniyu Rossijskoj federacii [The state of cancer care for the population of the Russian Federation]. Rossijskij onkologicheskij zhurnal [Russian Journal of Oncology]. 2016; 1: 5. (in Russ.)].

9. Ларичев А.Б., Рябов М.М., Кузьмин В.С., [и др.]. Квинтэссенция заживления раны перинеальной области после брюшно-промежностной экстирпации прямой кишки // Инфекции в хирургии. – 2023. – No 21 (1). – C.47-52. [Larichev AB, Ryabov MM, Kuz’min VS, et al. Kvintessenciya zazhivleniya rany perineal’noj oblasti posle bryushno-promezhnostnoj ekstirpacii pryamoj kishki [The quintessence of wound healing in the perineal region after abdominoperineal extirpation of the rectum]. Infekcii v hirurgii [Infections in surgery]. 2023; 21 (1): 47-52. (in Russ.)].

10. Kato S, Miyoshi N, Fujino S, Minami S, Nagae A, Hayashi R, Sekido Y, Hata T, Hamabe A, Ogino T, Tei M, Kagawa Y, Takahashi H, Uemura M, Yamamoto H, Doki Y, Eguchi H. Treatment response prediction of neoadjuvant chemotherapy for rectal cancer by deep learning of colonoscopy images. Oncol Lett. 2023; 26 (5):474. DOI: 10.3892/ol.2023.14062

11. Wang L, Zhang T, Zheng Y, Li Y, Tang X, Chen Q, Mao W, Li W, Liu X, Zhu J. Combination of irinotecan silicasome nanoparticles with radiation therapy sensitizes immunotherapy by modulating the activation of the cGAS/ STING pathway for colorectal cancer. Mater Today Bio. 2023; 23:100809. DOI: 10.1016/j.mtbio.2023.100809

12. Бутенко А. В., Шехтер А.Б., Файзуллин А.Л., [и др.]. Различные способы доставки оксида азота для стимуляции раневого заживления // Гены и Клетки. – 2019. – No 14S. – С.45-45. [Butenko AV, Shexter AB, Fajzullin AL, et al. Razlichnye sposoby dostavki oksida azota dlya stimulyacii ranevogo zazhivleniya [Various Methods of Nitric Oxide Delivery to Promote Wound Healing]. Geny i Kletki [Genes and Cells]. 2019; 14S: 45-45. (in Russ.)].

13. Глушков Н.И., Беляев А.М., Горшенин Т.Л. Современные возможности в улучшении результатов лечения больных пожилого и старческого возраста с осложненными формами рака ободочной кишки // Успехи геронтологии. – 2022. – No 35 (2). – С.255-262. [Glushkov NI, Belyaev AM, Gorshenin TL. Sovremennye vozmozhnosti v uluchshenii rezul’tatov lecheniya bol’nyh pozhilogo i starcheskogo vozrasta s oslozhnennymi formami raka obodochnoj kishki [Modern opportunities to improve the results of treatment of elderly and senile patients with complicated forms of colon cancer]. Uspekhi gerontologii [Advances in gerontology]. 2022; 35 (2): 255-262. (in Russ.)]. DOI: 10.34922/AE.2022.35.2.009

14. Lima HA, Woldesenbet S, Moazzam Z, Endo Y, Munir MM, Shaikh C, Rueda BO, Alaimo L, Resende V, Pawlik TM. Association of Minority-Serving Hospital Status with Post-Discharge Care Utilization and Expenditures in Gastrointestinal Cancer. Ann Surg Oncol. 2023; 30 (12): 7217-7225. DOI: 10.1245/s10434-023-14146-3

15. Щерба С.Н., Савченко Ю.П. Сравнительный анализ ранних послеоперационных осложнений у больных среднего и пожилого возраста, оперированных по поводу колоректального рака // Клиническая геронтология. – 2016. – No 22(11-12). – С. 47-51. [Shcherba SN, Savchenko YUP. Sravnitel’nyj analiz rannih posleoperacionnyh oslozhnenij u bol’nyh srednego i pozhilogo vozrasta, operirovannyh po povodu kolorektal’nogo raka [Comparative analysis of early postoperative complications in middle-aged and elderly patients operated on for colorectal cancer]. Klinicheskaya gerontologiya [Clinical gerontology]. 2016; 22 (11-12): 47-51. (in Russ.)].

16. Малышева Ю.В., Тихомирова И.А., Рябов М.М., Кислов Н.В. Реологические свойства крови у пациентов с колоректальным раком до и после операции // Тромбоз, гемостаз и реология. – 2016. – No S3 (67). – С.274-275. [Malysheva YuV, Tihomirova IA, Ryabov MM, Kislov NV. Reologicheskie svojstva krovi u pacientov s kolorektal’nym rakom do i posle operacii [Rheological properties of blood in patients with colorectal cancer before and after surgery]. Tromboz, gemostaz i reologiya [Thrombosis, hemostasis and rheology]. 2016; S3 (67): 274-275. (in Russ.)].

17. ZhangS,TangB,YuM,HeL,ZhengP,YanC,LiJ,PengQ. Development and Validation of a Radiomics Model Based on Lymph-Node Regression Grading After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2023; 117 (4): 821-833. DOI: 10.1016/j.ijrobp.2023.05.027

18. Юдин А.А., Кохнюк В.Т., Колядич Г.И. Отдаленные результаты лечения пациентов с низколокализованнным раком прямой кишки // Тазовая хирургия и онкология. – 2019. – No 9 (1). – С.26-33. [Yudin AA, Kohnyuk VT, Kolyadich GI. Otdalennye rezul’taty lecheniya pacientov s nizkolokalizovannnym rakom pryamoj kishki [Long-term results of treatment of patients with low-localized rectal cancer]. Tazovaya hirurgiya i onkologiya [Pelvic surgery and oncology]. 2019; 9 (1): 26-33. (in Russ.)].

19. Baron TH. Management of Infected Pancreatic Necroses: An Endoscopic Approach. The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery. 2023; 260-265.

20. Крашенков О.П., Иваников И.О., Константинова Ю.С., [и др.]. Современные подходы к организации онкологической помощи больным колоректальным раком (обзор литературы) // Доказательная гастроэнтерология. – 2021. – No 10 (1). – С.17-29. [Krashenkov OP, Ivanikov IO, Konstantinova YuS, et al. Sovremennye podhody k organizacii onkologicheskoj pomoshchi bol’nym kolorektal’nym rakom (obzor literatury) [Modern approaches to organizing oncological care for patients with colorectal cancer (literature review)]. Dokazatel’naya gastroenterologiya [Evidence-based gastroenterology]. 2021; 10 (1): 17-29. (in Russ.)].

21. Гильмутдинова И.Р., Еремин П.С., Фесюн А.Д., Бутенко А.В. Применение методов экстракорпоральной гемокоррекции в комплексной терапии злокачественных опухолей и реабилитации онкологических больных // Сибирский онкологический журнал. – 2020. – No19(5). – С.114-120. [Gil’mutdinova IR, Eremin PS, Fesyun AD, Butenko AV. Primenenie metodov ekstrakorporal’noj gemokorrekcii v kompleksnoj terapii zlokachestvennyh opuholej i reabilitacii onkologicheskih bol’nyh [Application of extracorporeal hemocorrection methods in complex therapy of malignant tumors and rehabilitation of cancer patients]. Sibirskij onkologicheskij zhurnal [Siberian Journal of Oncology]. 2020; 19 (5); 114-120. (in Russ.)]. DOI: 10.21294/1814-4861-2020-19-5-114-120

22. Тойчуев З.М., Гатауллин И.Г. Современные подходы в профилактике параколостомических осложнений у больных колоректальным раком // Колопроктология. – 2015. – No S1. – С.113a-114. [Tojchuev ZM, Gataullin IG. Sovremennye podhody v profilaktike parakolostomicheskih oslozhnenij u bol’nyh kolorektal’nym rakom [Modern approaches to the prevention of paracolostomy complications in patients with colorectal cancer]. Koloproktologiya [Coloproctology]. 2015; S1: 113a-114. (in Russ.)].

23. Ding PR. Application of Molecular Profiling in Colorectal Cancer Surgery. Clin Colon Rectal Surg. 2023; 36 (6): 367-368. DOI: 10.1055/s-0043-1767702

24. Bertoy L, Harbaugh CM, Millis MA, Zhuo L, Gutsche N, Beck G, Panzer K, Howard R, Weng W, Singh K, Englesbe M, Hendren S. Positive margin rates for colorectal cancer vary significantly by hospital in Michigan: Can we achieve a 0 % positive margin rate? Surg Open Sci. 2023; 16: 37-43. DOI: 10.1016/j.sopen.2023.09.005

25. Зитта Д.В., Субботин В.М., Бусырев Ю.Б. Применение программы оптимизации периопераицонного периода в хирургии рака прямой кишки // Колопроктология. – 2019. – No 18(S3). – С.64-64. [Zitta DV, Subbotin VM, Busyrev YUB. Primenenie programmy optimizacii perioperaiconnogo perioda v hirurgii raka pryamoj kishki [Application of a program for optimizing the perioperative period in rectal cancer surgery]. Koloproktologiya [Coloproctology]. 2019; 18 (S3): 64-64. (in Russ.)].

26. Gao Y, Wu A. Organ Preservation in MSS Rectal Cancer. Clin Colon Rectal Surg. 2023 Apr 16; 36 (6): 430-440. DOI: 10.1055/s-0043-1767710

27. Wang PP, Deng CL, Wu B. Magnetic resonance imaging-based artificial intelligence model in rectal cancer. World J Gastroenterol. 2021; 27 (18): 2122-2130. DOI: 10.3748/ wjg.v27.i18.2122

28. Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K. ASO Visual Abstract: Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer. Ann Surg Oncol. 2023; 30 (12): 7637-7638. DOI: 10.1245/s10434-023-14105-y

29. Мерабишвили В.М. Дубовиченко Д.М., Вальков М.Ю., [и др.]. Возрастные особенности динамики заболеваемости и смертности, локализационной и гистологической структур рака прямой кишки (популяционное исследование) // Успехи геронтологии. – 2020. – No 33 (5). – С.900-907. [Merabishvili VM, Dubovichenko DM, Val`kov MYu, et al. Vozrastnye osobennosti dinamiki zabolevaemosti i smertnosti, lokalizacionnoj i gistologicheskoj struktur raka pryamoj kishki (populyacionnoe issledovanie) [Age-related features of the dynamics of morbidity and mortality, localization and histological structures of rectal cancer (population study)]. Uspekhi gerontologii [Advances in gerontology]. 2020; 33 (5): 900-907. (in Russ.)].

30. Рахматов К.К. Сфинктеросохраняющая хирургия при дистальном раке прямой кишки: интерсфинктеральная резекция с коло-анальным анастомозом // Материалы X Юбилейной Международной научно-практической конференции молодых ученых-медиков, Курск, 26–27 февраля 2016 года / Под редакцией В.А. Лазаренко, И.Э. Есауленко, Р.Ш. Хасанова. Том 2. – Курск: Общество с ограниченной ответственностью «МедТестИнфо», 2016. – С. 230-232. [Rakhmatov KK. Sfinkterosokhranyayushchaya khirurgiya pri distal’nom rake pryamoy kishki: intersfinkteral’naya rezektsiya s kolo-anal’nym anastomozom; Materialy X Yubileynoy Mezhdunarodnoy nauchno-prakticheskoy konferentsii molodykh uchenykh-medikov, Kursk, 26–27 fevralya 2016 goda, pod redaktsiyey VA Lazarenko, IE Yesaulenko, RSH Khasanova [Sphincter-sparing surgery for distal rectal cancer: intersphincteric resection with colo-anal anastomosis; Materials of the X Anniversary International Scientific and Practical Conference of Young Medical Scientists, Kursk, February 26–27, 2016, edited by VA Lazarenko, IE Esaulenko, RSH Khasanov]. Kursk: Obshchestvo s ogranichennoy otvetstvennost’yu “MedTestInfo” [Kursk: Limited Liability Company “MedTestInfo”]. 2016; 2: 230-232. (in Russ.)].

31. Varlamos CJ, Sinco B, Van Weiren I, Regenbogen S, Gamboa AC, Silviera M, Abdel-Misih SRZ, Hawkins AT, Balch G, Hendren S. Close distal margin is associated with locoregional rectal cancer recurrence: A multicenter study. J Surg Oncol. 2023; 128 (7): 1106-1113. DOI: 10.1002/jso.27401

32. Ларичев А.Б., Бабаджанян А.Р., Фомин А.Н., [и др.]. Клинико-фармакокинетические параллели периоперационной антибиотикопрофилактики в абдоминальной хирургии // Российский медицинский журнал. – 2018. – No 24 (2). – С.73-77. [Larichev AB, Babadzhanyan AR, Fomin AN, et al. Kliniko-farmakokineticheskie paralleli perioperacionnoj antibiotikoprofilaktiki v abdominal’noj hirurgii [Clinical and pharmacokinetic parallels of perioperative antibiotic prophylaxis in abdominal surgery]. Rossijskij medicinskij zhurnal [Russian Medical Journal]. 2018; 24 (2): 73-77. (in Russ.)].

33. Родоман Г.В., Мальгина Н.В., Разбирин В.Н., [и др.]. Метод локального отрицательного давления в профилактике инфекционных раневых осложнений промежностной раны после брюшно-промежностной экстирпации прямой кишки // Перитонит от а до я (Всероссийская школа) : Материалы IX Всероссийской конференции общих хирургов с международным участием, Ярославль, 18–19 мая 2016 года / Под редакцией А.Б. Ларичева. – Ярославль: «Аверс-Плюс», 2016. – С. 786-788. [Rodoman GV, Mal’gina NV, Razbirin VN, et al. Metod lokal’nogo otritsatel’nogo davleniya v profilaktike infektsionnykh ranevykh oslozhneniy promezhnostnoy rany posle bryushno-promezhnostnoy ekstirpatsii pryamoy kishki; Peritonit ot a do ya (Vserossiyskaya shkola) : Materialy IX Vserossiyskoy konferentsii obshchikh khirurgov s mezhdunarodnym uchastiyem, Yaroslavl’, 18–19 maya 2016 goda, pod redaktsiyey AB Laricheva [Method of local negative pressure in the prevention of infectious wound complications of the perineal wound after abdominoperineal extirpation of the rectum; Peritonitis from A to Z (All-Russian School): Materials of the IX All-Russian Conference of General Surgeons with international participation, Yaroslavl, May 18–19, 2016, edited by AB Larichev]. Yaroslavl’: «Avers-Plyus» [Yaroslavl: «Avers-Plus».]. 2016; 786-788. (in Russ.)].

34. Kucejko RJ, Breen EM, Kleiman DA, Kuhnen AH, Marcello PW, Saraidaridis JT, Abelson JS. A Growing Divide? Social Determinants of the Use of Nonoperative Management of Rectal Cancer and Its Impact on Survival. J Surg Res. 2023; 292: 137-143. DOI: 10.1016/j.jss.2023.06.045

35. Peng Y, Huang M, Kao C. Prevalence of Depression and Anxiety in Colorectal Cancer Patients: A Literature Review. Int J Environ Res Public Health. 2019; 16 (3): 411. DOI: 10.3390/ijerph16030411

36. Aminisani N, Nikbakht H, Asghari Jafarabadi M, Shamshirgaran SM. Depression, anxiety, and health related quality of life among colorectal cancer survivors. J Gastrointest Oncol. 2017; 8: 81–88. DOI: 10.21037/ jgo.2017.01.12

37. Ткаченко Г.А., Калашникова И.А., Мусаев И.Э., Кузьмичев Д.В., Полыновский А.В. Психологическая реабилитация больных колоректальным раком // Колопроктология. – 2022. – No 21 (3). – С.85–91. [Tkachenko GA, Kalashnikova IA, Musaev IE, Kuz’michev DV, Polynovskij AV. Psihologicheskaya reabilitaciya bol’nyh kolorektal’nym rakom [Psychological rehabilitation of patients with colorectal cancer]. Koloproktologiya [Coloproctology]. 2022; 21 (3): 85–91. (in Russ.)]. DOI: 10.33878/2073-7556-2022-21-3-8

38. Dressler J, Njor SH, Jørgensen LN, Rasmussen M. Less Invasive Primary Treatment for Colorectal Cancer After Implementation of National Screening: A Nationwide
    Cohort Study. World J Surg. 2023; 47 (11): 2877-2887. DOI: 10.1007/s00268-023-07142-x

39. Schäfer AO. Update Rektumkarzinom: postneoadjuvantes Staging [Rectal cancer update: postneoadjuvant staging]. Radiologie (Heidelb). 2023; 63 (6): 451-456. German. DOI: 10.1007/s00117-023-01152-5

40. Максимова П.Е., Крамарь Т.В. Влияние опухолевого микроокружения на резистентность терапии колоректального рака // Медицинская наука Крыма: от истоков к современности: сборник материалов Научно-практической конференции, Симферополь, 22 декабря 2022 года / Крымский федеральный университет имени В. И. Вернадского, Институт «Медицинская академия имени С. И. Георгиевского». – Симферополь: Федеральное государственное автономное образовательное учреждение высшего образования «Крымский федеральный университет имени В.И. Вернадского», 2022. – С.113-118. [Maksimova PE, Kramar’ TV. Vliyaniye opukholevogo mikrookruzheniya na rezistentnost’ terapii kolorektal’nogo raka; Meditsinskaya nauka Kryma: ot istokov k sovremennosti : sbornik materialov Nauchno-prakticheskoy konferentsii, Simferopol’, 22 dekabrya 2022 goda; Krymskiy federal’nyy universitet imeni VI Vernadskogo, Institut «Meditsinskaya akademiya imeni SI Georgiyevskogo» [The influence of the tumor microenvironment on treatment resistance in colorectal cancer; Medical science of Crimea: from origins to the present: collection of materials of the Scientific and Practical Conference, Simferopol, December 22, 2022; Crimean Federal University named after VI Vernadsky, Institute “Medical Academy named after VI Georgievsky”]. Simferopol’: Federal’noye gosudarstvennoye avtonomnoye obrazovatel’noye uchrezhdeniye vysshego obrazovaniya “Krymskiy federal’nyy universitet imeni VI Vernadskogo” [Simferopol: Federal State Autonomous Educational Institution of Higher Education “Crimean Federal University named after VI Vernadsky”]. 2022; 113-118. (in Russ.)].

41. Русин И.В., Побылец А.М., Кояло С.И., Хильмончик И.В. Лапароскопические операции в хирургическом отделении // Актуальные проблемы медицины: сборник материалов итоговой научно-практической конференции, Гродно, 26 января 2023 года. – Гродно: Гродненский государственный медицинский университет, 2023. – С.329-330. [Rusin IV, Pobylec AM, Koyalo SI, Hil’monchik IV. Laparoskopicheskiye operatsii v khirurgicheskom otdelenii; Aktual’nyye problemy meditsiny: sbornik materialov itogovoy nauchno-prakticheskoy konferentsii, Grodno, 26 yanvarya 2023 goda [Laparoscopic operations in the surgical department; Current problems of medicine: collection of materials from the final scientific and practical conference, Grodno, January 26, 2023]. Grodno: Grodnenskiy gosudarstvennyy meditsinskiy universitet [Grodno: Grodno State Medical University.]. 2023; 329-330. (in Russ.)].

42. Федянин М.Ю., Гладков О.А., Гордеев С.С., [и др.]. Практические рекомендации по лекарственному лечению рака ободочной кишки и ректосигмоидного соединения // Злокачественные опухоли. – 2021. – No 11 (3S2-1). – С.330-372. [Fedyanin My, Gladkov OA, Gordeev SS, et al. Prakticheskie rekomendacii po lekarstvennomu lecheniyu raka obodochnoj kishki i rektosigmoidnogo soedineniya [Practical recommendations for drug treatment of colon and rectosigmoid cancer]. Zlokachestvennye opuholi [Malignant tumors]. 2021; 11 (3S2-1): 330-372. (in Russ.)].

43. Горелик С.Г., Дуганова М.В. Реабилитация стомированных больных // Медицинская сестра. – 2017. – No (5). – С.34-36. [Gorelik SG, Duganova MV. Reabilitaciya stomirovannyh bol’nyh [Rehabilitation of ostomy patients]. Medicinskaya sestra [Nurse]. 2017; (5): 34-36. (in Russ.)].

44. Костин А.А., Крашенков О.П., Коновалов О.Е., Иваников И.О. Организация наблюдения пациентов третьей клинической группы после лечения неоплазий колоректальной локализации // Кремлевская медицина. Клинический вестник. – 2022. – No 3. – С.65-68. [Kostin AA, Krashenkov OP, Konovalov OE, Ivanikov IO. Organizaciya nablyudeniya pacientov tret’ej klinicheskoj gruppy posle lecheniya neoplazij kolorektal’noj lokalizacii [Organization of observation of patients of the third clinical group after treatment of colorectal neoplasia]. Kremlevskaya medicina; Klinicheskij vestnik [Kremlin medicine; Clinical Bulletin]. 2022; 3: 65-68. (in Russ.)]. DOI: 10.26269/9m4d-bm84

45. Сидоров Д.В., Бакасов И.А., Ложкин М.В., Гришин Н.А. Статус циркулярного края резекции и непреднамеренная перфорация стенки кишки при брюшно-промежностной экстирпации прямой кишки // VII Петербургский международный онкологический форум «Белые Ночи 2021»: Тезисы форума. Материалы VII Петербургского международного онкологического форума, СанктПетербург, 21–27 июня 2021 года. – Санкт-Петербург: Вопросы онкологии, 2021. – С.11. [Sidorov DV, Bakasov IA, Lozhkin MV, Grishin NA. Status tsirkulyarnogo kraya rezektsii i neprednamerennaya perforatsiya stenki kishki pri bryushno-promezhnostnoy ekstirpatsii pryamoy kish; VII Peterburgskiy mezhdunarodnyy onkologicheskiy forum “Belyye Nochi 2021” : Tezisy foruma; Materialy VII Peterburgskogo mezhdunarodnogo onkologicheskogo foruma, Sankt-Peterburg, 21–27 iyunya 2021 goda [Status of the circular resection margin and unintentional perforation of the intestinal wall during abdominoperineal extirpation of the rectum; VII St Petersburg International Oncology Forum “White Nights 2021”: Abstracts of the forum; Materials of the VII St Petersburg International Oncology Forum, St Petersburg, June 21–27, 2021]. Sankt-Peterburg: Voprosy onkologii [St Petersburg: Oncology issues]. 2021; 11. (in Russ.)].

46. Гриценко Е.В., Алексеева А.В., Оловянная Н.П., Васильева Н.Г. Диспансерное наблюдение больных с онкологическими заболеваниями в условиях поликлиники // Вопросы медицинской реабилитации: Сборник научных трудов по итогам Межрегиональной научно-практической конференции, Чебоксары, 21 сентября 2018 года. – Чебоксары: Чувашский государственный университет имени И.Н. Ульянова, 2018. – С. 117-120 [Gritsenko YEV, Alekseyeva AV, Olovyannaya NP, Vasil’yeva NG. Dispansernoye nablyudeniye bol’nykh s onkologicheskimi zabolevaniyami v usloviyakh polikliniki; Voprosy meditsinskoy reabilitatsii : Sbornik nauchnykh trudov po itogam Mezhregional’noy nauchno-prakticheskoy konferentsii , Cheboksary, 21 sentyabrya 2018 goda [Dispensary observation of patients with cancer in a clinic; Issues of medical rehabilitation: Collection of scientific papers based on the results of the Interregional Scientific and Practical Conference, Cheboksary, September 21, 2018]. Cheboksary: Chuvashskiy gosudarstvennyy universitet imeni IN Ul’yanova [Cheboksary: Chuvash State University named after IN Ulyanov]. 2018; 117-120. (in Russ.)].

47. Хасанов Р.Ш., Камалов И.А. Профилактика тромбоэмболии лёгочной артерии у онкологических больных в течение первого года диспансерного наблюдения // Казанский медицинский журнал. – 2015. – No 96 (1). – С.13-16. [Hasanov RSh, Kamalov IA. Profilaktika tromboembolii lyogochnoj arterii u onkologicheskih bol’nyh v techenie pervogo goda dispansernogo nablyudeniya [Prevention of pulmonary embolism in cancer patients during the first year of follow-up]. Kazanskij medicinskij zhurnal [Kazan Medical Journal]. 2015; 96 (1): 13-16. (in Russ.)]. DOI: 10.17750/KMJ2015-013

1. Boehncke WH, Schon MP. Psoriasis. Lancet. 2015; 386 (9997): 983–94. DOI: 10.1016/S0140-6736(14)61909-7

2. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009; 361 (5): 496–509. DOI:10.1056/NEJMra0804595

3. Reed WB, Becker SW. Psoriasis and arthritis. A clinicopathological study. Archives of Dermatology. 1961; 83: 541

4. Menter A, Griffiths CEM, Tebbey PW, et al. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol. 2010; 24 (12): 1371-7. DOI: 10.1111/j.1468-3083.2010.03656.x

5. Кузьмина О.А., Миронова О. Ю., Фомин В.В. Сердечно-сосудистые заболевания у пациентов с псориазом в клинической практике: клинический случай // Евразийский кардиологический журнал. – 2022. – No1. – С.94– 99. [Kuz’mina OA, Mironova OYU, Fomin VV. Serdechno-sosudistye zabolevaniya u pacientov s psoriazom v klinicheskoj praktike: klinicheskij sluchaj [Cardiovascular diseases in patients with psoriasis in clinical practice: a clinical case]. Evrazijskij kardiologicheskij zhurnal [Eurasian Cardiology Journal]. 2022; 1: 94-99. (In Russ.)]. DOI.10.38109/2225-1685-2022-1-94-99

6. Egeberg A, Thyssen JP, Jensen P, et al. Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: A nationwide cohort study. Acta Derm Venereol. 2017; 97: 819–824. DOI: 10.2340/00015555-2657

7. Heredi E, Vegh J, Pogacsas L, et al. Subclinical cardiovascular disease and it’s improvement after long-term TNF-alpha inhibitor therapy in severe psoriatic patients. J Eur Acad Dermatol. Venereol. JEADV. 2016; 30: 1531–1536. DOI: 10.1111/jdv.13649. Epub 2016 Jul 9

8. Хотко А.А., Руднева Н.С. Кардиоваскулярные риски у пациентов с псориазом (обзор литературы) // Медицинский алфавит. – 2021. – No34. – С.12–17. [Hotko AA, Rudneva NS. Kardiovaskulyarnye riski u pacientov s psoriazom (obzor literatury) [Cardiovascular risks in patients with psoriasis (literature review)]. Medicinskij alfavit [Medical alphabet]. 2022; 1: 94–99. (In Russ.)].

9. von Stebut E, Reich K, Thaçi D, et al. Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks. J Invest Dermatol. 2019 May; 139 (5): 1054–1062. DOI: 10.1016/j.jid.2018.10.042

10. Anyfanti P, Margouta A, Goulas K, et al. Endothelial Dysfunction in Psoriasis: An Updated Review. Front Med (Lausanne). 2022; 9: 864185. DOI: 10.3389/ fmed.2022.864185

11. Hillary T, Clijmans J, Vermeire S, et al. Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis. Ann Med. 2021; 53 (1): 1074–1081. DOI: 10.1080/07853890.2021.1942974

12. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009; 129 (10): 2411-8. DOI: 10.1038/jid.2009.112

13. Boehncke WH. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences. Front Immunol. 2018; 9: 579. DOI: 10.3389/fimmu.2018.00579

14. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014; 70: 512–516. DOI: 10.1016/j. jaad.2013.11.013

15. Shiba M, Kato T, Izumi T, et al. Risk of myocardial infarction in patients with psoriasis: A cross-sectional patient-population study in a Japanese hospital. J Cardiol. 2019; 73 (4): 276–279. DOI: 10.1016/j.jjcc.2018.10.008

16. Caiazzo G, Fabbrocini G, Di Caprio R, et al. Psoriasis, cardiovascular events, and biologics: lights and shadows. Front Immunol. 2018; 9: 1668. DOI: 10.3389/ fimmu.2018.01668

17. Puig Lluı ́s. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2018; 19 (1): 58. DOI: 10.3390/ijms19010058

18. Toussirot E, Gallais-Sérézal I, Aubin F. The cardiometabolic conditions of psoriatic disease. Front Immunol. 2022; 13: 970371. DOI: 10.3389/fimmu.2022.970371

19. Polachek A, Touma Z, Anderson M, et al. Risk of cardiovascular morbidity in patients with psoriatic arthritis: A meta-analysis of observational studies. Arthritis Care Res. 2017; 69 (1): 67–74. DOI: 10.1002/acr.22926

20. Eder L, Wu Y, Chandran V, et al. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Ann Rheum Dis. 2016; 75 (9): 1680–1686. DOI: 10.1136/ annrheumdis-2015-207980

21. Eder L, Thavaneswaran A, Chandran V, et al. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis. Ann Rheum Dis. 2015; 74(10): 1830–1835. DOI: 10.1136/annrheumdis-2014-205267

22. Liu L, Cui S, Liu M, et al. Psoriasis increased the risk of adverse cardiovascular outcomes: A new systematic review and meta-analysis of cohort study. Front Cardiovasc Med. 2022; 9: 829709. DOI: 10.3389/fcvm.2022.829709

23. Chen TL, Lee LL, Huang HK, et al. Association of psoriasis with incident venous thromboembolism and peripheral vascular disease: A systematic review and meta-analysis. JAMA Dermatol. 2022; 158: 59–67. DOI: 10.1001/ jamadermatol.2021.4918

24. Chin YY, Yu HS, Li WC, et al. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: A nation-wide study. J Eur Acad Dermatol Venereol. 2013; 27 (10): 1262–8. DOI: 10.1111/j.1468-3083.2012.04706.x

25. Husted JA, Thavaneswaran A, Chandran V, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis. Arthritis Care Res. 2011; 63 (12): 1729–1735. DOI: 10.1002/acr.20627

26. Ogdie A, Yu Y, Haynes K, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: A population-based cohort study. Ann Rheum Dis. 2015; 74 (2): 326–32. DOI: 10.1136/ annrheumdis-2014-205675

27. Puig L. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2017; 19 (1): 58. DOI: 10.3390/ijms19010058

28. Yuan Z, Guo Y. Risk of incident type 2 diabetes in patients with psoriatic arthritis: A systematic review and meta-analysis of cohort studies. Int J Rheum Dis. 2022; 25 (9): 1029-1037. DOI: 10.1111/1756-185X.14375

29. Jamnitski A, Symmons D, Peters MJ, et al. Cardiovascular comorbidities in patients with psoriatic arthritis: A systematic review. Ann Rheum Dis. 2013; 72 (2): 211–6. DOI: 10.1136/annrheumdis-2011-201194

30. Mok CC, Ko GT, Ho LY, et al. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res. 2011; 63 (2): 195–202. DOI: 10.1002/acr.20363

31. Tam LS, Tomlinson B, Chu TT, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls–the role of inflammation. Rheumatol (Oxford). 2008; 47 (5): 718–23. DOI: 10.1093/rheumatology/ken090

32. Jafri K, Bartels CM, Shin D, et al. Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: A population-based study. Arthritis Care Res. 2017; 69 (1): 51–57. DOI: 10.1002/ acr.23094

33. Husted JA, Thavaneswaran A, Chandran V, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis. Arthritis Care Res. 2011; 63 (12): 1729–1735. DOI: 10.1002/acr.20627

34. Hao Y, Zhu YJ, Zou S, et al. Metabolic syndrome and psoriasis: Mechanisms and future directions. Front Immunol. 2021; 12: 711060. DOI: 10.3389/ fimmu.2021.711060

35. Karmacharya P, Ogdie A, Eder L. Psoriatic arthritis and the association with cardiometabolic disease: A narrative review. Ther Adv Musculoskelet Dis. 2021; 13: 1759720X21998279. DOI: 10.1177/1759720X21998279

36. Haroon M, Gallagher P, Heffernan E, et al. High prevalence ofmetabolicsyndromeandofinsulinresistanceinpsoriatic arthritis is associated with the severity of underlying disease. J Rheumatol. 2014; 41 (7): 1357–65. DOI: 10.3899/jrheum.140021

37. Lin IC, Heck JE, Chen L, et al. Psoriasis severity and cardiometabolic risk factors in a representative us national study. Am J Clin Dermatol. 2021; 22 (5): 719–30. DOI: 10.1007/s40257-021-00600-z

38. Chin YY, Yu HS, Li WC, et al. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: A nation-wide study. J Eur Acad Dermatol Venereol. 2013; 27 (10): 1262–1268. DOI: 10.1111/j.1468-3083.2012.04706.x

39. Mok CC, Ko GT, Ho LY, et al. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res. 2011; 63 (2): 195–202. DOI: 10.1002/acr.20363

40. Loganathan A, Kamalaraj N, El-Haddad C, et al. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis. Int J Rheum Dis. 2021; 24: 1112–1120. DOI: 10.1111/1756-185X.14147

41. Teklu M, Parel PM, Mehta NN. Psoriasis and cardiometabolic diseases: The impact of inflammation on vascular health. Psoriasis (Auckl). 2021; 11: 99–108. DOI: 10.2147/PTT. S320016

42. Castaneda S, Nurmohamed MT, Gonzalez-Gay MA. Cardiovascular disease in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. 2016; 30 (5): 851–69. DOI: 10.1016/j.berh.2016.10.006

43. Ferguson LD, Siebert S, McInnes IB, et al. Cardiometabolic comorbidities in Ra and psa: Lessons learned and future directions. Nat Rev Rheumatol. 2019; 15 (8): 461–74. DOI: 10.1038/s41584-019-0256-0

44. Armstrong EJ, Krueger JG. Lipoprotein metabolism and inflammation in patients with psoriasis. Am J Cardiol. 2016; 118 (4): 603–9. DOI: 10.1016/j.amjcard.2016.05.060

45. Sarwar N, Butterworth AS, Freitag DF, et al. IL6R Genetics Consortium Emerging Risk Factors Collaboration, Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012; 379: 1205–1213. DOI: 10.1016/S0140-6736(11)61931-4

46. Hotamisligil GS. Inflammation and metabolic disorders. Nature.2006;444(7121):860–867.DOI:10.1038/ nature05485

47. Chehimi M, Vidal H, Eljaafari A. Pathogenic role of il-17-Producing immune cells in obesity, and related inflammatory diseases. J Clin Med. 2017; 6 (7): 68. DOI: 10.3390/jcm6070068

48. Toussirot E. Mini-review: The contribution of adipokines to joint inflammation in inflammatory rheumatic diseases. Front Endocrinol (Lausanne). 2020; 11: 606560. DOI: 10.3389/fendo.2020.606560

1. Syrian Arab republic: Covid-19 update no. 03-25 March 2020. Situation report, OCHA, WHO. 25 Mar 2020. Available at: https://reliefweb.int/report/ syrian-arab-republic/syrian-arab-republic-covid-19-update-no-03-25-march-2020?fbclid=IwAR3YrN5_q-N0ku9HCkduGiPIMMs6ClLaENzryjkL-3YQPVzrL_ L2oMwldGA (Accessed: 28 November, 2023).

2. Abo Kasem R, Almansour M. COVID-19 during the crisis in the Syrian Arab Republic. East Mediterr Health J. 2021; 27(1): 5–6. DOI:10.26719/2021.27.1.5

3. Syrian Arab Republic: Covid-19 Update no. 05-10 April 2020. Situation report, OCHA, WHO. 10 Apr 2020. Available at: https://reliefweb.int/report/syrian-arab-republic/syrian-arab-republic-covid-19-update-no-05-10-april-2020 (Accessed: 28 November, 2023).

4. Alrasheedi AA. COVID-19 Statistics in the Arab World by the End of October 2022: A Cross-Sectional Study. Cureus. 2022; 14 (12): e32670. DOI:10.7759/cureus.32670

5. WHO Syria Monthly COVID-19 Bulletin (December 2022). Situation report, WHO. 25 Jan 2023. Available at: https://reliefweb.int/report/syrian-arab-republic/who-syria-monthly-covid-19-bulletin-december-2022 (Accessed: 28 November, 2023).

6. Najjar M, Albuaini S, Fadel M, Aljbawi A, Mohsen F, Sulaiman S, Koudsi A. COVID-19 Disease in Syrian Patients With Cancer: Clinical Manifestations, Laboratory Findings, Treatment, and Outcomes. JCO Glob Oncol. 2022; 8: e2100283. DOI:10.1200/GO.21.00283

7. Syrian Arab Republic: COVID-19 Weekly Epidemiological Bulletin | EPI Week: 22W28 (10 – 16 July 2022) 18 July 2022. Situation report, WHO. 18 Jul 2022. Available at: https://reliefweb.int/report/syrian-arab-republic/syrian-arab-republic-covid-19-weekly-epidemiological-bulletin-epi-week-22w28-10-16-july-2022-18-july-2022 (Accessed: 28 November, 2023).

8. Edouard Mathieu, Hannah Ritchie, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, Saloni Dattani, Diana Beltekian, Esteban Ortiz-Ospina and Max Roser. Coronavirus Pandemic (COVID-19). Published online at OurWorldInData.org. Available at: https://ourworldindata.org/coronavirus [Online Resource] (Accessed: 28 November, 2023).

9. WHO Syria monthly Covid-19 Bulletin (December 2022). Situation report, WHO. 25 Jan 2023. Available at: https:// reliefweb.int/report/syrian-arab-republic/who-syria-monthly-covid-19-bulletin-december-2022 (Accessed: 28 November, 2023).

10. Nassar RI, Thiab S, Alkoudsi KT, Basheti IA. COVID-19 infected patients’ experiences in Syria, and the role of the pharmacists during their infection. Pharm Pract (Granada). 2022; 20 (1): 2617. DOI:10.18549/PharmPract.2022.1.2617

11. Daw MA. The Impact of Armed Conflict on the Epidemiological Situation of COVID-19 in Libya, Syria and Yemen. Front Public Health. 2021; 9: 667364. DOI: 10.3389/ fpubh.2021.667364

12. United Nations. Syria: As coronavirus threat intensifies, ceasefire more urgent than ever. UN news, Global perspective Human stories. Available at: https://news.un.org/ en/story/2020/04/1062862 (Accessed: 28 November, 2023).

13. Bizri NA, Alam W, Mobayed T, Tamim H, Makki M, Mushrrafieh U. COVID-19 in conflict region: the arab levant response. BMC Public Health. 2021; 21 (1): 1590. DOI:10.1186/s12889-021-11580-4

14. Mazen Gharibah, Zaki Mehchy. Covid-19 Pandemic: Syria’s Response and Healthcare Capacity. The London school of economics and political science. 2020. Available at: https://eprints.lse.ac.uk/103841/1/CRP_covid_19_in_ Syria_policy_memo_published.pdf (Accessed: 28th of November, 2023).

15. Swed S, Bohsas H, Alibrahim H, Hafez W, Shoib S, Sawaf B, Rais MA, Aljabali A, Shaheen N, Elsayed M, Rakab A. Health-care provider burnout in Syria during COVID-19 pandemic’s Omicron wave. Medicine (Baltimore). 2022; 101 (50): e32308. DOI:10.1097/MD.0000000000032308

16. Syrian Arab Republic: Covid-19 Update no. 05-10 April 2020. Situation report, OCHA, WHO. Available at: https:// reliefweb.int/report/syrian-arab-republic/syrian-arab-
    republic-covid-19-update-no-05-10-april-2020 (Accessed: 28 November, 2023).

17. The socio-economic impacts of the COVID-19 pandemic in the Syrian Arab Republic (April – June 2020). World Food Programme, 2020. Available at: https://syria.un.org/ en/137874-syria-socio-economic-impacts-covid-19-pandemic-october-2020 (Accessed: 28 November, 2023).

18. Kakaje A, Mansour S, Ghareeb A. Was a forced lockdown adequate for a country in conflict? A psychological perspective from the Syrian population. Qatar Med J. 2021; 2021 (1): 17. DOI:10.5339/qmj.2021.17

19. Forman R, Ciancaglini L, Garces PSJ, Neli M, Mossialos E. Another crisis in the sorrowland: COVID-19 in northeast Syria. J Glob Health. 2022; 12: 03033. DOI:10.7189/ jogh.12.03033

20. Shibani M, Alzabibi MA, Mouhandes AE, Alsuliman T, Mouki A, Ismail H, Alhayk S, Rmman AA, Mansour M, Marrawi M, Alhalabi N, Habib MB, Albuni MK, Al-Moujahed A, Sawaf B; Data Collection Group. COVID-19 vaccination acceptance among Syrian population: a nationwide cross-sectional study. BMC Public Health. 2021; 21 (1): 2117. DOI:10.1186/s12889-021-12186-6

21. Mohamad O, Zamlout A, AlKhoury N, et al. Factors associated with the intention of Syrian adult population to accept COVID19 vaccination: a cross-sectional study. BMC Public Health. 2021; 21: 1310. DOI:10.1186/s12889-021-11361-z

1. Torres–González EJ, Zamarripa–Jáuregui RG, Carrillo– Martínez JM, et al. Prevalence of overweight and obesity in school–age children. Gac Med Mex. 2020; 156 (3): 182–186. DOI: 10.24875/GMM.M20000390

2. Tsoi MF, Li HL, Feng Q, et al. Prevalence of Childhood Obesity in the United States in 1999–2018: A 20–Year Analysis. Obes Facts. 2022; 15 (4): 560–569. DOI: 10.1159/000524261

3. Nittari G, Scuri S, Petrelli F, et al. Fighting obesity in children from European World Health Organization member states. Epidemiological data, medical–social aspects, and prevention programs. Clin Ter. 2019; 170 (3): 223–230. DOI: 10.7417/CT.2019.2137

4. Окороков П.Л., Васюкова О.В., Ширяева Т.Ю. Скорость основного обмена в покое и факторы его вариабельности у подростков с простым ожирением // Вопросы детской диетологии. – 2019. T. 17, вып. 3. – С.5–9. [Okorokov PL, Vasyukova OV, Shiryaeva TYu. Skorost’ osnovnogo obmena v pokoe i faktory ego variabel’nosti u podrostkov s prostym ozhireniem [Resting metabolic rate and factors of its variability in adolescents with obesity]. Voprosy detskoj dietologii [Pediatric Nutrition]. 2019; 17 (3): 5–9. (In Russ.)]. DOI: 10.20953/1727–5784–2019–3–5–9

5. Дахкильгова Х.Т. Детское ожирение: современное состояние // Вопросы детской диетологии. – 2019. – Т. 17, вып. 5. – С.47–53. [Dakhkilgova KhT. Detskoe ozhirenie: sovremennoe sostoyanie [Childhood obesity:the current state of the problem]. Voprosy detskoj dietologii [Pediatric Nutrition]. 2019; 17 (5): 47–53. (In Russ.)]. DOI: 10.20953/1727–5784–2019–5–47–53

6. DeBoer M. Assessing and Managing the Metabolic Syndrome in Children and Adolescents. Nutrients. 2019; 11 (8): 81–88. DOI: 10.3390/nu11081788

7. Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes. 2018; 9 (4): 308–325. DOI: 10.1080/19490976.2018.1465157

8. Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World J Gastroenterol. 2015; 21 (29): 8787–8803. DOI: 10.3748/wjg.v21.i29.8787

9. Allam–Ndoul B, Castonguay–Paradis S, Veilleux A. Gut Microbiota and Intestinal Trans–Epithelial Permeability. International Journal of Molecular Sciences. 2020; 21 (17): E6402. DOI: 10.3390/ijms21176402

10. Cuevas–Sierra A, Ramos–Lopez O, Riezu–Boj JI, et al. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications. Advances in Nutrition. 2019; 10 (1): 17–30. DOI: 10.1093/advances/ nmy078

11. Stiemsma LT, Michels KB. The Role of the Microbiome in the Developmental Origins of Health and Disease. Pediatrics. 2018; 141 (4): e20172437. DOI: 10.1542/ peds.2017–2437

12. Brines J, Rigourd V, Billeaud C. The First 1000 Days of Infant. Healthcare. 2022; 10: 106. DOI: 10.3390/ healthcare10010106

13. Le Doare K, Holder B, Bassett A, Pannaraj PS. Mother’s Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. Front Immunol. 2018; 9: 361. DOI: 10.3389/fimmu.2018.00361

14. Francino MP. Birth Mode–Related Differences in Gut Microbiota Colonization and Immune System Development. Ann Nutr Metab. 2018; 73 (3): 12–16. DOI: 10.1159/000490842

15. Carr LE, Virmani MD, Rosa F, et al. Role of Human Milk Bioactives on Infants’ Gut and Immune Health. Front Immunol. 2021; 12: 604080. DOI: 10.3389/ fimmu.2021.604080

16. Lyons KE, Ryan CA, Dempsey EM, et al. Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health. Nutrients. 2020; 12 (4): 1039. DOI: 10.3390/ nu12041039

17. Mueller NT, Whyatt R, Hoepner L, et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes. 2015; 39 (4): 665–670. DOI: 10.1038/ ijo.2014.180

18. Masukume G, Khashan AS, Morton SMB, et al. Caesarean section delivery and childhood obesity in a British longitudinal cohort study. PLoS One. 2019; 14 (10): e0223856. DOI: 10.1371/journal.pone.0223856

19. Ahlqvist VH, Persson M, Magnusson C, Berglind D. Elective and nonelective cesarean section and obesity among young adult male offspring: A Swedish population– based cohort study. PLoS Med. 2019; 16 (12): e1002996. DOI: 10.1371/journal.pmed.1002996

20. Gómez–Gallego C, Morales JM, Monleón D, et al. Human Breast Milk NMR Metabolomic Profile across Specific Geographical Locations and Its Association with the Milk Microbiota. Nutrients. 2018; 10 (10): 1355. DOI: 10.3390/ nu10101355

21. Solís G, de Los Reyes–Gavilan CG, Fernández N, et al. Establishment and development of lactic acid bacteria and bifidobacteria microbiota in breast–milk and the infant gut. Anaerobe. 2010; 16 (3): 307–310. DOI: 10.1016/j. anaerobe.2010.02.004

22. Ma J, Qiao Y, Zhao P, Li W, et al. ISCOLE Research Group. Breastfeeding and childhood obesity: A 12–country study. Matern Child Nutr. 2020; 16 (3): e12984. DOI: 10.1111/mcn.12984

23. Stokholm J, Schjørring S, Eskildsen CE, et al. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect. 2014; 20 (7): 629–635. DOI: 10.1111/1469–0691.12411

24. Reyman M, van Houten MA, Watson RL, et al. Effects of early–life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nat Commun. 2022; 13 (1): 893. DOI: 10.1038/s41467–022– 28525–z

25. Abenavoli L, Scarpellini E, Colica C, et al. Gut Microbiota and Obesity: A Role for Probiotics. Nutrients. 2019; 11 (11): E2690. DOI: 10.3390/nu11112690

26. Самойлова Ю.Г., Саган Е.В., Олейник О.А., [и др.]. Таксономическая характеристика микробиоты толстого кишечника и ее взаимосвязь с эндокринной системой у детей и подростков с избыточной массой тела и ожирением // Педиатрия. Журнал им. Г.Н. Сперанского. – 2022. – Т. 101, вып. 5. – С.23–32. [Samojlova YuG, Sagan EV, Olejnik OA, et al. Taksonomicheskaya harakteristika mikrobioty tolstogo kishechnika i ee vzaimosvyaz’ s endokrinnoj sistemoj u detej i podrostkov s izbytochnoj massoj tela i ozhireniem [Taxonomic characteristics of the microbiota of the large intestine and its relationship with the endocrine system in overweight and obese children and adolescents]. Pediatriya; Zhurnal imeni GN Speranskogo [Pediatriya named after GN Speransky]. 2022; 101 (5): 23–32. (In Russ.)]. DOI: 10.24110/0031–403X–2022– 101–5–23–32

27. Galaris A, Fanidis D, Stylianaki EA, et al. Obesity Reshapes the Microbial Population Structure along the Gut–Liver–Lung Axis in Mice. Biomedicines. 2022; 10 (2): 494. DOI: 10.3390/biomedicines10020494

28. Borgo F, Verduci E, Riva A, et al. Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study. Child Obes. 2017; 13 (1): 78–84. DOI: 10.1089/chi.2015.019

29. Sun J, Qiao Y, Qi C, et al. High–fat–diet–induced obesity is associated with decreased antiinflammatory Lactobacillus reuteri sensitive to oxidative stress in mouse Peyer’s patches. Nutrition. 2016; 32 (2): 265–272. DOI: 10.1016/j. nut.2015.08.020

30. Indiani CMDSP, Rizzardi KF, Castelo PM, et al. Childhood Obesity and Firmicutes/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review. Child Obes. 2018; 14 (8): 501–509. DOI: 10.1089/chi.2018.0040

31. Ignacio A, Fernandes MR, Rodrigues VA, et al. Correlation between body mass index and faecal microbiota from children. Clin Microbiol Infect. 2016; 22 (3): 258. DOI: 10.1016/j.cmi.2015.10.031

32. Петрова П.Ю., Ага А.Д., Трапезникова Е.С., Буданова Е.В. Состав кишечной микробиоты как фактор риска развития ожирения у детей // Анализ риска здоровью. – 2021. – Вып. 1. – С.159–172. [Petrova PYu, Aga AD, Trapeznikova ES, Budanova EV. Sostav kishechnoj mikrobioty kak faktor riska razvitiya ozhireniya u detej [The composition of the intestinal microbiota as a risk factor for obesity in children]. Analiz riska zdorov’yu [Health Risk Analysis]. 2021; 1: 159–172 (In Russ.)]. DOI: 10.21668/ health.risk/2021.1.17

33. Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021; 137: 111315. DOI: 10.1016/j.biopha.2021.111315

34. Crovesy L, Masterson D, Rosado EL. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020; 74 (9): 1251–1262. DOI: 10.1038/ s41430–020–0607–6

35. Derrien M, Belzer C, de Vos WM. Akkermansia muciniphila and its role in regulating host functions. Microb Pathog. 2017; 106: 171–181. DOI: 10.1016/j.micpath.2016.02.005

36. Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners. Gut. 2020; 69 (12): 2232–2243. DOI: 10.1136/gutjnl–2020–322260

37. Macchione IG, Lopetuso LR, Ianiro G, et al. Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders. Eur Rev Med Pharmacol Sci. 2019; 23 (18): 8075–8083. DOI: 10.26355/eurrev_201909_19024

38. Abdul Rahim MBH, Chilloux J, Martinez–Gili L, et al. Diet– induced metabolic changes of the human gut microbiome: importance of short–chain fatty acids, methylamines and indoles. Acta Diabetol. 2019; 56 (5): 493–500. DOI: 10.1007/s00592–019–01312–x

39. Agus A, Clément K, Sokol H. Gut microbiota–derived metabolites as central regulators in metabolic disorders. Gut. 2021; 70 (6): 1174–1182. DOI: 10.1136/ gutjnl–2020–323071

40. Martin–Gallausiaux C, Marinelli L, Blottière HM, et al. SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc. 2021; 80 (1): 37–49. DOI: 10.1017/ S0029665120006916

41. Portincasa P, Bonfrate L, Vacca M, et al. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. International Journal of Molecular Sciences. 2022; 23 (3): 1105. DOI: 10.3390/ijms23031105

42. Sonnenburg JL, Bäckhed F. Diet–microbiota interactions as moderators of human metabolism. Nature. 2016; 535 (7610): 56–64. DOI: 10.1038/nature18846

43. Canfora EE, Jocken JW, Blaak EE. Short–chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015; 11 (10): 577–591. DOI: 10.1038/ nrendo.2015.128

44. Кайтмазова Н.К. Микробиота кишечника и ее влияние на организм // Современные вопросы биомедицины. – 2022. – Т. 6, вып. 3. – С.20. [Kajtmazova NK. Mikrobiota kishechnika i ee vliyanie na organism [Gut microbiota and its effect on the body]. Sovremennye voprosy biomediciny [Modern Issues of Biomedicine]. 2022; 6 (3): 20. (In Russ.)]. DOI: 10.51871/2588–0500_2022_06_03_8

45. Hernández MAG, Canfora EE, Jocken JWE, Blaak EE. The Short–Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. Nutrients. 2019; 11 (8): E1943. DOI: 10.3390/nu11081943

46. Frost G, Sleeth ML, Sahuri–Arisoylu M, et al. The short–chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 2014; 5: 3611. DOI: 10.1038/ncomms4611

47. Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The Gut Microbiota and Inflammation: An Overview. International Journal of Environmental Research and Public Health. 2020; 17 (20): E7618. DOI: 10.3390/ijerph17207618

48. Kim H, Jeong Y, Kang S, et al. Co–Culture with Bifidobacterium catenulatum Improves the Growth, Gut Colonization, and Butyrate Production of Faecalibacterium prausnitzii: In Vitro and In Vivo Studies. Microorganisms. 2020; 8 (5): 788. DOI: 10.3390/microorganisms8050788

49. Beisner J, Filipe Rosa L, Kaden–Volynets V, et al. Prebiotic Inulin and Sodium Butyrate Attenuate Obesity–Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides. Front Immunol. 2021; 12: 678360. DOI: 10.3389/ fimmu.2021.678360

50. Coppola S, Avagliano C, Calignano A, Berni Canani R. The Protective Role of Butyrate against Obesity and Obesity–Related Diseases. Molecules. 2021; 26 (3): 682. DOI: 10.3390/molecules26030682

51. Anachad O, Taouil A, Taha W, et al. The Implication of Short–Chain Fatty Acids in Obesity and Diabetes. Microbiology Insights. 2023; 16: 11786361231162720. DOI: 10.1177/11786361231162720

52. Ziętek M, Celewicz Z, Szczuko M. Short–Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy. Nutrients. 2021; 13 (4): 1244. DOI: 10.3390/nu13041244

53. Ilyés T, Silaghi CN, Crăciun AM. Diet–Related Changes of Short–Chain Fatty Acids in Blood and Feces in Obesity and Metabolic Syndrome. Biology. 2022; 11 (11): 1556. DOI: 10.3390/biology11111556

54. Neag MA, Craciun AE, Inceu AI, et al. Short–Chain Fatty Acids as Bacterial Enterocytes and Therapeutic Target in Diabetes Mellitus Type 2. Biomedicines. 2022; 11 (1): 72. DOI: 10.3390/biomedicines11010072

55. Murugesan S, Nirmalkar K, Hoyo–Vadillo C, et al. Gut microbiome production of short–chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis. 2018; 37 (4): 621–625. DOI: 10.1007/s10096–017–3143–0

1. Al Mahmasani L, Finianos A, Bou–fakhredin R, et al. Acquired hemophilia A: When an overlooked autoimmune disorder causes signifi can’t bleeding. Expert Opin Orphan Drugs. 2020; 8 (2–3): 79–89. DOI: 10.1080/21678707.2 020.1740682

2. Kessler CM, Ma AD, Al–Mondhiry HA, et al. Assessment of acquired hemophilia patient demographics in the United States: the hemostasis and thrombosis research society registry. Blood Coagulation and Fibrinolysis. 2016; 27 (7): 761–769. DOI: 10.1097/MBC.0000000000000582

3. Maria EM, Ramiro N, Francisco JR. Acquired haemophilia: Epidemiology, clinical presentation, diagnosis and treatment. Medicina Clinica. 2017; 148 (7): 314–322. DOI: 10.1016/j.medcle.2016.11.041

4. Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J ThrombHaemost. 2012; 10 (4): 622–631. DOI: 10.1111/j.1538–7836.2012.04654.x

5. Franchini M, Vaglio S, Marano G, et al. Acquired hemophilia A: A review of recent data and new therapeutic options. Hematology. 2017; 22 (9): 514–520. DOI: 10.108 0/10245332.2017.1319115

6. Tengborn L, Baudo F, Huth–Kühne A, et al. Pregnancy– associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG. 2012; 119 (12): 1529–1537. DOI: 10.1111/j.1471– 0528.2012.03469.x

7. Wootla B, Mahendra A, Dimitrov J. Factor VIII – hydrolyzing IgG in acquired and congenital hemophilia. FEBS Letters. 2009; 583 (15): 2565–2572. DOI: 10.1016/j. febslet.2009.07.009

8. Andreas T, Peter C, Paul K, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020; 105 (7): 1791–1801. DOI: 10.3324/haematol.2019.230771

9. Lippi G, Favaloro EJ. Preanalytical issues in hemostasis and thrombosis testing. Methods Mol Biol. 2017; 1646: 29–42. DOI: 10.1007/978–1–4939–7196– 1_2

10. Суренков А.А., Орел Е.Б., Зозуля Н.И., Двирнык В.Н. Особенности клинико-лабораторной диагностики редкой коагулопатии – приобретенной гемофилии // Гематология и трансфузиология. – 2022. – Т. 67, вып. 4. – С.535–550. [Surenkov AA, Orel EB, Zozulya NI, Dvirnyk VN. Osobennosti kliniko–laboratornoj diagnostiki redkoj koagulopatii — priobretennoj gemofilii [Features of clinical and laboratory diagnosis of rare coagulopathy — acquired hemophilia]. Gematologiya i transfuziologiya [Russian journal of hematology and transfusiology]. 2022; 67 (4): 535–550 (In Russ.)]. DOI: 10.35754/0234–5730– 2022–67–4–535–550

11. Долгов В.В., Вавилова Т.В., Свирин П.В. Лабораторная диагностика нарушений гемостаза // Тверь: Триада, 2019. – 400 с. [Dolgov VV, Vavilova TV, Svirin PV. Laboratornaya diagnostika narushenij gemostaza [Laboratory diagnosis of hemostatic disorders]. Tver: Triada [Tver: Triada]. 2019; 400 p. (In Russ.).].

12. Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia A: Limitations, consequences and challenges. Semin Thromb Hemost. 2014; 40 (7): 803–811. DOI: 10.1055/s–0034–1390004

13. Mazzucconi MG, Baldacci E, Ferretti A, et al. Acquired haemophilia A: An intriguing disease. Mediterr J Hematol Infect Dis. 2020; 12 (1): e2020045. DOI: 10.4084/ MJHID.2020.045

14. Collins P, Baudo F, Knoebl P, et al. Immunosuppression for acquired hemophilia A: Results from the European Acquired Haemophilia Registry (EACH2). Blood. 2012; 120 (1): 47–55. DOI: 10.1182/blood–2012–02–409185

15. Галстян Г.М., Налбандян С.А., Сабиров К.Р., [и др.]. Тактика лечения больной приобретенной гемофилией: непрерывная инфузия рекомбинантного активированного фактора свертывания VII и эрадикация ингибитора // Гематология и трансфузиология. – 2022. –Т. 67, вып. 2. – С.282–294. [Galstyan GM, Nalbandyan SA. Sabirov KR, et al. Taktika lecheniya bol’noj priobretennoj gemofiliej: nepreryvnaya infuziya rekombinantnogo aktivirovannogo faktora svertyvaniya VII i eradikaciya ingibitora [Treatment tactics for a patient with acquired hemophilia: continuous infusion of recombinant activated coagulation factor VII and the inhibitor eradication]. Gematologiya i transfuziologiya [Russian Journal of Hematology and Transfusiology]. 2022; 67 (2): 282–294 (In Russ.)]. DOI: 10.35754/0234–5730– 2022–67–2–282–294

1. Pearse AG. 5–hydroxytryptophan uptake by dog thyroid’C’cells and its possible significance in polypeptide hormone production. Nature. 1966; 211 (5049): 598–600. DOI: 10.1038/211598a0

2. Бабичев В.Н. Организация и функционирование нейро-эндокринной системы // Проблемы эндокринологии. – 2013. – Т. 59, No1. – С.62 – 69. [Babichev VN. Organizacija i funkcionirovanie nejrojendokrinnoj sistemy [Organization and functioning of the neuroendocrine system]. Problemy jendokrinologii [Problems of endocrinology]. 2013; 59 (1): 62–69. (In Russi.)]. DOI: 10.14341/probl201359162–69

3. Herder W, Rehfeld JF, Kidd М, Modlin IM. A short history of neuroendocrine tumours and their peptide hormones. Best Practice and Research Clinical Endocrinolology and Metabolism. 2016; 30(1): 3–17. DOI: 10.1016/j. beem.2015.10.004

4. Самотруева М.А., Ясенявская А.Л., Цибизова А.А., [и др.]. Нейроиммуноэндокринология: современные представления о молекулярных механизмах // Immunology. – 2017.– Т. 38, No 1. – С. 49– 59. [Samotrueva MA, Yasenyavskaya AL, Tsibizova АA, Bashkina OA, Galimzyanov HM, Tyurenkov IN. Nejroimmunojendokrinologija: sovremennye predstavlenija o molekuljarnyh mehanizmah [Neuroimmunoendocrinology: modern ideas about molecular mechanisms]. Immunologiya [Immunology]. 2017; 38 (1): 49–59. (in Russi.)]. DOI: 10.18821/0206–4952–2017–38–1–49–59

5. Dan Grigore A, Ben Jacob E, Farach MC. Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine? Front Oncol. 2015; 5: 37. DOI: 10.3389/ fonc.2015.00037

6. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia. 2017; 19 (12): 991–1002. DOI: 10.1016/j. neo.2017.09.002

7. Горбунова В.А. Нейроэндокринные опухоли. Общие принципы диагностики и лечения: практическое руководство / Москва: ГЭОТАР-Медиа, 2021. – 600 с. [Gorbunova VA. Nejrojendokrinnye opuholi; Obshhie principy diagnostiki i lechenija: prakticheskoe rukovodstvo [Neuroendocrine tumors; General principles of diagnosis and treatment: a practical guide]. Moskva: GJeOTAR-Media [Moscow: GJeOTAR-Media]. 2021; 600 p.].

8. Меньшиков К.В., Султанбаев А.В., Мусин Ш.И., [и др.]. Нейроэндокринные опухоли. Обзор литературы // Креативная хирургия и онкология. – 2021. – Т. 11, No 2. – С.174–182. [Men’shikov KV, Sultanbaev AV, Musin ShI, et al. Nejrojendokrinnye opuholi. Obzor literatury [Neuroendocrine tumors. Literature review]. Kreativnaja hirurgija i onkologija [Creative surgery and oncology]. 2021; 11 (2): 174–182. (in Russ.)]. DOI: 10.24060/2076–3093–2021–11–2–174–182

9. Чиж Г.А., Тютрина Ю.А., Проценко С.А. [и др.]. Современные представления о нейроэндокринном раке предстательной железы: клинический случай и обзор литературы // Современная Онкология. – 2022. – No 24 (2). – C.242–249. [Chizh GA, Tyutrina YuA, Protsenko SA, et al. Sovremennye predstavlenija o nejrojendokrinnom rake predstatel’noj zhelezy: klinicheskij sluchaj i obzor literatury [Current concepts of neuroendocrine cancer of the prostate: a clinical case and review of the literature]. Sovremennaja Onkologija [Journal of Modern Oncology]. 2022; 24 (2): 242– 249. (in Russ.)]. DOI: 10.26442/18151434.2022.2.201242

10. Carrillo D, Muñoz–Medel M, Retamal I, Pinto M, et al. Tumores Neuroendocrinos: un desafío transversal [Update on neuroendocrine tumors]. Rev Med Chil. 2021; 149 (6): 888–898. DOI: 10.4067/s0034–98872021000600888

11. Hofland J, Kaltsas G, W de Herder W. Advances in the Diagnosis and Management of Well–Differentiated Neuroendocrine Neoplasms. Endocr Rev. 2020; 41 (2): 371–403. DOI: 10.1210/endrev/bnz00412. Guadagno E, De Caro MDB, Insabato L. An update on the pathology of neuroendocrine tumors. Front Biosci (Schol Ed). 2016; 8 (1): 1–12. DOI: 10.2741/s442

13. Gut P. Oncological management of advanced neuro-endocrine tumours (Review). Mol Clin Oncol. 2020; 13 (3): 8. DOI: 10.3892/mco.2020.2078

14. Под ред. Кригер А.Г., Кармазановсий Г.Г., Паклина О.В. Нейроэндокринные опухоли поджелудочной железы. Диагностика и хирургическое лечение. Методическое руководство // Москва: Национальный медицинский исследовательский центр хирургии им. А.В. Вишневского, 2019 – 82 c. [Kriger AG, Karmazanovsij GG, Paklina OV ed. Neyroendokrinnyye opukholi podzheludochnoy zhelezy: Diagnostika i khirurgicheskoye lecheniye: Metodicheskoye rukovodstvo [Neuroendocrine tumors of the pancreas: Diagnosis and surgical treatment: Methodological manual]. Moskva: Natsional’nyy meditsinskiy issledovatel’skiy tsentr khirurgii imeni AV Vishnevskogo [Moscow: National Medical Research Center for Surgery named after AV Vishnevsky]. 2019; 82 p.

15. Ishida H, Lam AК. Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification. Crit Rev Oncol Hematol. 2022; 172: 103648. DOI: 10.1016/j. critrevonc.2022.103648

16. Rindi G, Mete O, Uccella S, Basturk O, et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022; 33 (1): 115–154. DOI: 10.1007/ s12022–022–09708–2

17. Клинические рекомендации «Нейроэндокринные опухоли» // Москва, 2021. – 87 с. [Klinicheskie rekomendacii «Nejrojendokrinnye opuholi». [Clinical guidelines “Neuroendocrine tumors]. Moscow. 2021; 87 p. Режим доступа [URL]: https://cr.minzdrav.gov.ru/schema/610_1? ysclid=lwiekv865238600695

18. Дроздов Е.С., Грищенко М.Ю., Харитонкин В.И., [и др.]. Редкое клиническое наблюдение пациента со смешанной нейроэндокринной-не-нейроэндокринной опухолью большого дуоденального соска // Сибирский онкологический журнал. – 2023. – Т. 22, No 2. – С.168– 174. [Drozdov ES, Grishchenko MYu, Kharitonkin VI, et al. Redkoe klinicheskoe nabljudenie pacienta so smeshannoj nejrojendokrinnoj–ne–nejrojendokrinnoj opuhol’ju bol’shogo duodenal’nogo soska [A rare clinical case of a patient with mixed neuroendocrine–non–neuroendocrine neoplasms of the ampulla of vater]. Sibirskij onkologicheskij [Siberian Journal of Oncology]. 2023; 22 (2): 168–174. (in Russ.)]. DOI: 10.21294/1814–4861–2023–22–2–168–174

19. Guilmette JM, Nosé V. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances. Adv Anat Pathol. 2019; 26 (1): 13–30. DOI: 10.1097/PAP.0000000000000201

20. Кригер А.Г. Актуальные вопросы хирургии опухолей поджелудочной железы // Хирургия. Журнал им. Н.И. Пирогова. – 2021. – No10. – С.5–12. [Kriger G. Aktual’nye voprosy hirurgii opuholej podzheludochnoj zhelezy [Actual issues of pancreatic tumor surgery]. Hirurgija: Zhurnal imeni NI Pirogova [Pirogov Russian Journal of Surgery]. 2021; 10: 5–12. (in Russ.)]. DOI: 10.17116/hirurgia20211015

21. Szarvas T, Csizmarik A, Fazekas T, Hüttl A, et al. Comprehensive analysis of serum chromogranin A and neuron–specific enolase levels in localized and castrationresistant prostate cancer. BJU Int. 2021; 127 (1): 44–55. DOI: 10.1111/bju.15086

22. Rossi RE, Ciafardini C, Sciola V, Conte D, Massironi S. Chromogranin A in the follow–up of gastroenteropancreatic neuroendocrine neoplasms: is it really game over? A systematic review and meta–analysis. Pancreas. 2018; 47 (10): 1249–1255. DOI: 10.1097/MPA.0000000000001184

23. Орел Н.Ф., Артамонова Е.В., Горбунова В.А., и др. Практические рекомендации по лекарственному лечению нейроэндокринных неоплазий желудочно–кишечного тракта, поджелудочной железы и других локализаций // Злокачественные опухоли. – 2021. – Т. 11, No3S2-1. – С.499–512. [Orel NF, Artamonova EV, Gorbunova VA, et al. Prakticheskie rekomendacii po lekarstvennomu lecheniju nejrojendokrinnyh neoplazij zheludochno–kishechnogo trakta, podzheludochnoj zhelezy i drugih lokalizacij [Practical guidelines on medical treatment of gastro–intestinal and pancreatic neuroendocrine tumors]. Zlokachestvennye opuholi [Malignant tumors]. 2021; 11 (3s2–1): 499–512. (in Russi.)]. DOI: 10.18027/2224–5057–2021–11–3s2–30

24. Rinke A. Practice guideline neuroendocrine tumors, AWMF– Reg, 021–27. Z Gastroenterol. 2018; 56 (6): 583–681. DOI: 10.1055/a–0604–2924

25. Baum RP, Kulkarni HR, Singh A, Kaemmerer D, et al. Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms. Oncotarget. 2018; 9 (24): 16932–16950. DOI: 10.18632/oncotarget.24524

26. Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, et al. 177Lu–Dotatate plus long–acting octreotide versus high–dose long–acting octreotide in patients with midgut neuroendocrine tumours (NETTER–1): final overall survival and long–term safety results from an open–label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021; 22 (12): 1752–1763. DOI: 10.1016/S1470–2045(21)00572–6

27. Тищенко В.К., Петриев В.М., Крылов В.В., [и др.]. Аналоги соматостатина, меченные радионуклидами, для терапии онкологических заболеваний. Обзор // Радиация и риск. 2022. – Т.31, No 2. – С.76–96. [Tishhenko VK, Petriev VM, Krylov VV, et al. Analogi somatostatina, mechennye radionuklidami, dlja terapii onkologicheskih zabolevanij: Obzor [Radiolabeled somatostatin analogs for cancer treatment: Review]. Radiacija i risk [Radiation and risk]. 2022; 31 (2): 76–96. (in Russ.)]. DOI: 10.21870/0131– 3878–2022–31–2–76–96

28. Ruggeri RM, Benevento E, De Cicco F, Fazzalari B, et al. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies. J Endocrinol Invest. 2023; 46 (1): 213–234. DOI: 10.1007/ s40618–022–01905–4

29. Özdirik B, Tacke F, Benz F, Amthauer H, et al. A case report of an excellent response to interferon – α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments. Medicine (Baltimore). 2020; 99 (25): e20820. DOI: 10.1097/MD.0000000000020820

30. Joybari AY, Azadeh P. Von Hippel–Lindau Disease With MultiOrgan Involvement: A Case Report and 8–Year Clinical Course With Follow–Up. The Am J Case Rep. 2017; 18: 1220–1224. DOI: 10.12659/ajcr.907356

31. Crespigio J, Berbel LCL, Dias MA, Berbel RF, et al. Von Hippel–Lindau disease: a single gene, several hereditary tumors. Journal of endocrinological investigation. 2018; 41 (1): 21–31. DOI: 10.1007/s40618–017–0683–1

32. Halperin R, Arnon L, Eden–Friedman Y, Tirosh А. Unique Characteristics of Patients with Von Hippel–Lindau Disease Defined by Various Diagnostic Criteria. Сancers (Basel). 2023; 15 (6): 1657. DOI: 10.3390/cancers15061657

33. Lam AK, Ishida H. Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging. Histol Histopathol. 2021; 36 (4): 367–382. DOI: 10.14670/ HH–18–288

34. Laks S, Rachel van Leeuwaarde, Patel D, Keutgen XM, et al. Management Recommendations for Pancreatic Manifestations of Von Hippel– Lindau Disease. Cancer. 2022; 128 (3): 435–446. DOI: 10.1002/cncr.33978

35. Halperin R, Tirosh А. Non–Interventional Management of Advanced Pancreatic Neuroendocrine Neoplasms in Patients with von Hippel–Lindau Disease. Cancers (Basel). 2023; 15 (6): 1739. DOI: 10.3390/cancers15061739

36. Binderup MLM, Jensen AM, Budtz–Jørgensen E, Bisgaard ML. Survival and causes of death in patients with von Hippel–Lindau disease. J Med Genet. 2017; 54 (1): 11–18. DOI: 10.1136/jmedgenet–2016–104058

37. Gläsker S, Vergauwen E, Koch CA, Kutikov A, et al. Von Hippel–Lindau Disease: Current Challenges and Future Prospects. Onco Targets Ther. 2020; 13: 5669–5690. DOI: 10.2147/OTT.S190753

38. Fallah J, Brave MH, Weinstock C, Mehta GU, et al. FDA Approval Summary: Belzutifan for von Hippel–Lindau Disease–Associated Tumors. Clin Cancer Res. 2022; 28 (22): 4843–4848. DOI: 10.1158/1078–0432.CCR–22–1054

1. Wismeijer D, Casentini P, Gallucci GO, Chiapasco M. Loading protocols in implant dentistry: Edentulous patients: ITI Treatment Guide Series. Quintessence Publishing. 2016; 4: 248.

2. Персин Л.С., [и др.]. Ортодонтия. Современные методы диагностики аномалий зубов, зубных рядов и окклюзии: учебное пособие. – Москва: ГЭОТАР–Медиа, 2021. – 160 с. [Persin LS. Ortodontiya; Sovremennyye metody diagnostiki anomaliy zubov, zubnykh ryadov i okklyuzii: uchebnoye posobiye [Orthodontics; Modern methods for diagnosing anomalies of teeth, dentition and occlusion: a textbook]. Moskva: GEOTAR–Media [Moscow: GEOTAR– Media]. 2021; 160 p.

3. edited by Jan Lindhe and Niklaus P. Orthodontics and periodontics: Part 17 – Clinical Periodontology and Implant Dentistry. USA: Wiley–Blackwell. 2021; 7 (1): 590–596.

4. Blanchet E, Buisson P, Marin N, Jenny R. Implant positioning for esthetic purposes: importance of guided surgery. Titane. 2009; special issue: 91–98.

5. Buser D, Chappuis V, Belser UC, Chen S. Implant placement post extraction in esthetic single tooth sites: when immediate, when early, when late? Periodontology 2000. 2017; 73 (1): 84–102. DOI: 10.1111/prd.12170

6. edited by Jan Lindhe and Niklaus P Lang. Peri–implant pathology; Part 7 – Clinical Periodontology and Implant Dentistry. USA: Wiley–Blackwell. 2021; 7 (1): 547–557.

7. Никитина Л.И., Архипова А.А., Громова А.С. Использование цифровых технологий при лечении первичной адентии боковых резцов верхней челюсти: в сборнике научных статей VI Всероссийской научно–практической конференции с международным участием «Актуальные вопросы стоматологии детского возраста». – Казань: КГМУ, 2023. – С.225–230. [Nikitina LI, Arhipova AA, Gromova AS. Ispol’zovaniye tsifrovykh tekhnologiy pri lechenii pervichnoy adentii bokovykh reztsov verkhney chelyusti: v sbornike nauchnykh statey VI Vserossiyskoy nauchno–prakticheskoy konferentsii s mezhdunarodnym uchastiyem «Aktual’nyye voprosy stomatologii detskogo vozrasta» [The use of digital technologies in the treatment of primary edentulism of the lateral incisors of the upper jaw: in the collection of scientific articles of the VI All–Russian Scientific and Practical Conference with international participation “Current issues in pediatric dentistry”]. Kazan’: KGMU [Kazan: KSMU]. 2023; 225–230. (In Russ.)].

8. Рубникович С.П., Денисова Ю.Л., Трояновская М.С. Особенности комплексного стоматологического лечения пациентов с первичной адентией боковых резцов // Medicina stomatologică. – 2020. – No 1 (54). – С.83–97. [Rubnicovich SP, Denisova YL, Troyanovskaya MS. Osobennosti kompleksnogo stomatologicheskogo lechenija pacientov s pervichnoj adentiej bokovyh rezcov [Peculiarities of complex dental treatment of patients with primary adentia of lateral incisors]. Medicina stomatologica [Dental medicine]. 2020; 1 (54): 83–97. (In Russ.)].

9. Никитина Л.И., Громова В.В. Комплексная терапия при отсутствии зубов // Труды X и XI Всероссийской научно–практической конференции Стоматологической ассоциации России. – Москва, 2003. – С.134–136. [Nikitina LI, Gromova VV. Kompleksnaya terapiya pri otsutstvii zubov [Complex therapy in the absence of teeth]. Trudy X i XI Vserossiiskoi nauchno–prakticheskoi konferentsii stomatologicheskoy assotsiatsii Rossii [Proceedings of the X and XI All–Russian Scientific and Practical Conference of the Dental Association of Russia]. Moskva [Moscow]. 2003; 134–136. (In Russ.)].

10. Никитина Л.И., Гилязева В.В., Громова А.С. Немедленная установка имплантатов в лунку удаленного зуба и немедленное временное протезирование – как метод совершенствования стоматологической реабилитации // Пульс. – 2022. – Т. 24, No 8. – С.20–25. [Nikitina LI, Gilyazeva VV, Gromova AS. Nemedlennaya ustanovka implantatov v lunku udalennogo zuba i nemedlennoe vremennoe protezirovanie – kak metod sovershenstvovaniya stomatologicheskoi reabilitacii [Immediate placement implants in the socket of the extracted tooth and immediate temporary prosthetics as a method for improving dental rehabilitation (review of literature data and own clinical experience)]. Pul’s [Pulse]. 2022; 24 (8): 20–25. (In Russ.)]. DOI: 10.26787/ NYDHA–2686–6838–2022–24–8–20–25

11. Никитина Л.И., Мухамеджанова Л.Р., Егоров М.А., Громова А.С. К вопросу об оценке состояния пародонта в области несъёмных конструкций с опорой на имплантах изготовленных по технологии CAD/CAM // Вестник современной клинической медицины. – 2022. – Т.15, вып.5. – С.52–57. [Nikitina LI, Mukchamedzhanova LR, Egorov MA, Gromova AS. K voprosu ob ocenke sostojanijaparodonta v oblasti nes’jomnyh konstrukcij s oporoj na implantah izgotovlennyh po tehnologii CAD/CAM [To the question about evaluation of the state of periodontal tissues in the area of fixed implant–supported prostheses made by CAD/CAM technology]. Vestnik sovremennoj klinicheskoj mediciny [The Bulletin of Contemporary Clinical Medicine]. 2022; 15 (5): 52–57. (In Russ.)]. DOI: 10.20969/VSKM.2022.15(5).52–57

12. Никитина Л.И. Дентальная имплантация при первичной адентии: оценка состояния регионарного кровотока; статья в сборнике трудов конференции «Современная стоматология». – Казань: КГМУ, 2017. – С.312–323. [Nikitina LI. Dental’naya implantatsiya pri pervichnoy adentii: otsenka sostoyaniya regionarnogo krovotoka; stat’ya v sbornike trudov konferentsii «Sovremennaya stomatologiya» [Dental implantation for primary adentia: assessment of the state of regional blood flow; article in the collection of proceedings of the conference “Modern Dentistry”]. Kazan’: KGMU [Kazan: KSMU]. 2017; 312– 323. (In Russ.)].

13. Никитина Л.И., Гилязева В.В., Громова А.С. Реабилитация пациентов с врождённым отсутствием зубов // Natural resources of the Earth and environmental protection. – 2023. – Т.4. No1. – C.63–68. [Nikitina LI, Gilyazeva VV, Gromova AS. Reabilitacija pacientov s vrozhdjonnym otsutstviem zubov [Rehabilitation of patients with congenital absence of tooth]. Natural resources of the Earth and environmental protection. 2023; 4 (1): 63–68. (In Russ.)].

14. Никитина Л.И., Константинова А.М., Громова А.С. Эстетические проблемы при врождённой адентии латеральных резцов верхних челюстей и пути решения: статья в сборнике трудов конференции «Медицинская наука и практика: междисциплинарный диалог». – Чебоксары: Чувашский государственный университет имени И.Н. Ульянова, 2022. – С.163–166. [Nikitina LI, Konstantinova AM, Gromova AS. Esteticheskiye problemy pri vrozhdonnoy adentii lateral’nykh reztsov verkhnikh chelyustey i puti resheniya: stat’ya v sbornike trudov konferentsii «Meditsinskaya nauka i praktika: mezhdistsiplinarnyy dialog» [Aesthetic problems with congenital edentia of the lateral incisors of the upper jaws and solutions: an article in the collection of proceedings of the conference “Medical Science and Practice: Interdisciplinary Dialogue”]. Cheboksary: Chuvashskiy gosudarstvennyy universitet imeni IN Ul’yanova [Cheboksary: Chuvash State University named after IN Ulyanova]. 2022; 163–166. (In Russ.)].

1. Иванов Ю.В., Панченков Д.Н. Лапароскопическая дивертикулэктомия при кровотечении из дивертикула двенадцатиперстной кишки // Эндоскопическая хирургия. ‒ 2019. ‒ Т. 25, No 2. ‒ С.47‒51. [Ivanov YV, Panchenkov DN. Laparoskopicheskaja divertikulectomija pri krovotechenii iz diverticula dvenadcatiperstnoy kishki [Laparoscopic diverticulectomy for bleeding from duodenal diverticulum]. Endoscopicheskaja hirurgija [Endoscopic Surgery]. 2019; 25 (2): 47‒51. (In Russ.)]. DOI: 10.17116/ endoskop20192502147

2. Гусев А.В., Говорливых А.Э., Соловьёв А.Ю. Забрюшинная перфорация дивертикула двенадцатиперстной кишки // Вестник Ивановской медицинской академии. – 2018 – Т. 23, No 2 – С.41‒43. [Gusev AV, Govorlivykh AE, Soloviev AY. Zabrushinnaja perforacija diverticula dvenadcatiperstnoy kishki [Retroperitoneal perforation of duodenal diverticulum]. Vestnik Ivanovskoy medicinskoy akademii [Bulletin of Ivanovo Medical Academy]. 2018; 23 (2): 41‒43. (In Russ.)].

3. Каплунова О.А., Чаплыгина Е.В., Крымшахалова С.Д., Суханова О.П. Анатомия забрюшинного пространства // Журнал фундаментальной медицины и биологии. – 2018 – No2. ‒С.45‒49. [Kaplunova OA, Chaplygina EV, Krimshakhalova SD, Sukhanova OP. Anatomija zabr’ushinnogo prostranstva [Anatomy of retroperitoneal space]. Jurnal fundamental’noy medicini I biologii [Journal of Fundamental Medicine and Biology]. 2018; 2: 45‒49. (In Russ)].

4. Хаджибаев Ф.А., Шукуров Б.И., Хошимов М. Юкстапапиллярные дивертикулы двенадцатиперстной кишки // Вестник экстренной медицины – 2014 – No3. – С.102‒107. [Hajibaev FA, Shukurov BI, Khoshimov M. Jukstapapill’arnije diverticuli dvenadcatiperstnoy kishki [Juxtapapillary diverticula of the duodenum]. Vestnik ekstrennoy medicini [Bulletin of Emergency Medicine]. 2014; 3: 102‒107 (In.Russ.)].

5. Haboubi D, Thapar A, Bhan C, et al. Perforated duodenal diverticulae: importance for the surgeon and gastroenterologist. BMJ Case Rep. 2014; 2014: bcr2014205859. DOI: 10.1136/bcr‒2014‒205859

6. Bittle MM, Gunn ML, Gross JA, Rohrmann CA. Imaging of duodenal diverticula and their complications. Curr Probl Diagn Radiol. 2012; 41 (1): 20‒29. DOI: 10.1067/j. cpradiol.2011.07.001

7. Rossetti A, Christian BN, Pascal B, et al. Perforated duodenal diverticulum, a rare complication of a common pathology: A seven‒patient case series. World J Gastrointest Surg. 2013; 5 (3): 47‒50. DOI: 10.4240/ wjgs.v5.i3.47

8. Thorson CM, Paz Ruiz PS, Roeder RA, et al. The perforated duodenal diverticulum. Arch Surg. 2012; 147 (1): 81‒88. DOI: 10.1001/archsurg.2011.821

9. Mitragkas P, Synekidou E, Hatzimisios K. Duodenal diverticulum perforation: a case report and review of the literature. Folia Med (Plovdiv). 2022; 64 (5): 849‒852. DOI: 10.3897/folmed.64.e66425

10. McKinley WI, Symalla T, Benjamin A. Management of the perforated duodenal diverticulum. Trauma Surg Acute Care Open. 2023; 8 (1): e001087. DOI: 10.1136/ tsaco‒2023‒001087